{"content":"<li class=\"n-box-item date-title\" data-end=\"1376107199\" data-start=\"1376020800\" data-txt=\"Friday, December 20, 2019\">Friday, August  9, 2013</li><li class=\"n-box-item sa-box-item\" data-id=\"1212962\" data-ts=\"1376094097\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INSG\" target=\"_blank\">INSG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1212962-novatel-wireless-continues-to-plummet\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Novatel Wireless continues to plummet</a></h4><ul>     <li>Novatel Wireless (NVTL <font color='red'>-5.2%</font>) fell again today, as the market continues digesting the company's Wednesday <a href=\"https://seekingalpha.com/currents/post/1204172\" target=\"_blank\">Q2 whiff</a>. Shares <font color='red'>dove 17.4%</font> this week, but remain <font color='green'>up 160%</font> YTD.</li>     <li>Q3 guidance for revenue of $90M-100M and EPS of -$0.14 to -$0.02 was in-line with consensus. (<a href=\"https://seekingalpha.com/article/1616512-novatel-wireless-ceo-discusses-q2-2013-results-earnings-call-transcript\" target=\"_blank\">CC</a>)</li>     <li>Novatel has now missed analyst estimates the past 4 quarters (<a href=\"https://seekingalpha.com/currents/post/1204172\" target=\"_blank\">I</a>, <a href=\"https://seekingalpha.com/currents/post/1006331\" target=\"_blank\">II</a>, <a href=\"https://seekingalpha.com/currents/post/844411\" target=\"_blank\">III</a>, <a href=\"https://seekingalpha.com/currents/post/649761\" target=\"_blank\">IV</a>), but the fallen dot-com bubble darling has nonetheless been on a tear after <a href=\"https://www.google.com/finance?chdnp=1&amp;chdd=1&amp;chds=1&amp;chdv=1&amp;chvs=maximized&amp;chdeh=0&amp;chfdeh=0&amp;chdet=1358888400000&amp;chddm=102550&amp;chls=IntervalBasedLine&amp;q=NASDAQ:NVTL&amp;ntsp=1&amp;ei=iIQFUsGvBci7igK5IA\" target=\"_blank\">plunging in 2012</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1212962\" data-linked=\"Novatel Wireless continues to plummet\" data-tweet=\"$INSG - Novatel Wireless continues to plummet https://seekingalpha.com/news/1212962-novatel-wireless-continues-to-plummet?source=tweet\" data-url=\"https://seekingalpha.com/news/1212962-novatel-wireless-continues-to-plummet\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:21 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1212402\" data-ts=\"1376092925\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TWER\" target=\"_blank\">TWER</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1212402-towerstream-sells-off-on-mediocre-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Towerstream sells off on mediocre Q2 results</a></h4><ul><li>Towerstream (<a href='https://seekingalpha.com/symbol/TWER-OLD' title='Towerstream Corporation'>TWER</a> <font color='red'>-7.2%</font>) dove after the company delivered so-so <a href=\"https://seekingalpha.com/currents/post/1210402\" target=\"_blank\">Q2 results</a>.</li><li>ARPU <a href=\"http://finance.yahoo.com/news/towerstream-reports-second-quarter-2013-200000990.html\" target=\"_blank\">increased</a>&nbsp;5% Y/Y to $740 (up for the fifth consecutive quarter).&nbsp;ARPU for new customers was up 34.2% Y/Y to $630, and up 1.6% Q/Q.</li><li>Rising wireless data demand in urban areas is expected to be a growth driver for the company. Towerstream is betting carriers will rely on its Wi-Fi offerings to address capacity needs.</li><li>Highlight: the company signed a long-term Wi-Fi lease agreement with a major cable operator in Q2. CEO Jeffrey Thompson: \"Securing the first anchor tenant for our neutral host network ... validates our rent-based business model.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"1212402\" data-linked=\"Towerstream sells off on mediocre Q2 results\" data-tweet=\"$TWER $TWER-OLD - Towerstream sells off on mediocre Q2 results https://seekingalpha.com/news/1212402-towerstream-sells-off-on-mediocre-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/1212402-towerstream-sells-off-on-mediocre-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1213552\" data-ts=\"1376087098\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INO\" target=\"_blank\">INO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1213552-more-on-inovio-pharmaceuticals-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Inovio Pharmaceuticals earnings</a></h4><ul>\n<li>Inovio Pharmaceuticals (NYSEMKT:<a href=\"https://seekingalpha.com/symbol/INO\" title=\"Inovio Pharmaceuticals, Inc.\">INO</a>) posts a <a href=\"https://seekingalpha.com/market_currents/post/1213362\" target=\"_blank\">mixed Q2</a>, beating on revenue but coming up short on a per share basis as losses were greater than expected.</li>\n<li>Total revenue rose Y/Y, primarily due to higher revenue recognized from its PATH Malaria Vaccine Initiative grant, its U.S. DoD Small Business Innovation Research Grant and its grant subcontract with the University of Pennsylvania.</li>\n<li>Per share losses also increased however, primarily from a higher mark-to-market change in fair value of common stock warrants, as well as a decrease in the fair market value of its investment in its affiliated entity, VGX International.</li>\n<li>Shares <font color=\"red\">-12.5%</font> AH.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1213552\" data-linked=\"More on Inovio Pharmaceuticals earnings\" data-tweet=\"$INO - More on Inovio Pharmaceuticals earnings https://seekingalpha.com/news/1213552-more-on-inovio-pharmaceuticals-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/1213552-more-on-inovio-pharmaceuticals-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1213532\" data-ts=\"1376085999\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PBR\" target=\"_blank\">PBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1213532-petrobras-swings-to-q2-profit-on-higher-fuel-prices\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Petrobras swings to Q2 profit on higher fuel prices</a></h4><ul>     <li>Petrobras (NYSE:<a href=\"https://seekingalpha.com/symbol/PBR\" title=\"Petrobras - Petroleo Brasileiro S.A.\">PBR</a>) swings to a <a href=\"http://online.wsj.com/article/BT-CO-20130809-713398.html\" target=\"_blank\">Q2 net profit</a> of 6.2B Brazilian reais ($2.73M), above the BRL5.3B analyst consensus, as higher fuel prices reverse a year-ago loss.</li>     <li>EBITDA came in at BRL18.1B vs. BRL10.6B in the year-ago period.</li>     <li>Revenue rose to BRL73.6B, +8.2% Y/Y, as Brazil's domestic gasoline prices rose 2.3% and diesel prices gained 5.6%, according to the Agora brokerage.</li>     <li>Shares <font color=\"green\">+2.2%</font> AH.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1213532\" data-linked=\"Petrobras swings to Q2 profit on higher fuel prices\" data-tweet=\"$PBR - Petrobras swings to Q2 profit on higher fuel prices https://seekingalpha.com/news/1213532-petrobras-swings-to-q2-profit-on-higher-fuel-prices?source=tweet\" data-url=\"https://seekingalpha.com/news/1213532-petrobras-swings-to-q2-profit-on-higher-fuel-prices\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1212992\" data-ts=\"1376085175\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DTLK\" target=\"_blank\">DTLK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1212992-datalink-claws-back-losses-after-pricing-new-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Datalink claws back losses after pricing new offering</a></h4><ul>     <li>Datalink (<a href=\"https://seekingalpha.com/symbol/DTLK\" title=\"Datalink Corporation\">DTLK</a> <font color=\"green\">+2.3%</font>) clawed backed some of the week's losses after<a href=\"http://finance.yahoo.com/news/datalink-announces-pricing-common-stock-130500920.html\" target=\"_blank\"> pricing</a> the 3.3M share public offering (and 495K overallotment) it <a href=\"http://finance.yahoo.com/news/datalink-announces-proposed-public-offering-110000266.html\" target=\"_blank\">announced</a> on Monday at $11/share. Shares nonetheless <font color=\"red\">fell 11%</font> on the week. (<a href=\"http://www.sec.gov/Archives/edgar/data/1056923/000104746913008281/a2216341z424b2.htm#base_of_pro\" target=\"_blank\">Prospectus</a>)</li>\n<li>The offering is set to close on Aug. 14.</li>\n<li>With offering proceeds of $33.8M, a new $40M channel finance and revolving credit facility, and $23M in cash in hand, the stage has been set for CEO Paul Lidsky to continue Datalink's aggressive <a href=\"https://seekingalpha.com/currents/post/847611\" target=\"_blank\">acquisition strategy.</a>\n</li>\n<li>The company previously acquired rival Stratech for $13.2M in cash and $23.1M in stock in Oct. 2012. Datalink is aiming for one acquisition every 12-18 months. (<a href=\"http://www.sec.gov/Archives/edgar/data/1056923/000110465913059079/a13-13661_110q.htm\" target=\"_blank\">10Q</a>)</li> </ul><div class=\"tiny-share-widget\" data-id=\"1212992\" data-linked=\"Datalink claws back losses after pricing new offering\" data-tweet=\"$DTLK - Datalink claws back losses after pricing new offering https://seekingalpha.com/news/1212992-datalink-claws-back-losses-after-pricing-new-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/1212992-datalink-claws-back-losses-after-pricing-new-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:52 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1213502\" data-ts=\"1376084686\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WLT\" target=\"_blank\">WLT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1213502-coal-stocks-rally-on-improved-moodys-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Coal stocks rally on improved Moody&#39;s outlook</a></h4><ul>     <li>Coal stocks (NYSEARCA:<a href=\"https://seekingalpha.com/symbol/KOL\" title=\"VanEck Vectors Coal ETF\">KOL</a>) <a href=\"http://blogs.barrons.com/stockstowatchtoday/2013/08/09/coal-rallies-on-improved-moodys-outlook\" target=\"_blank\">rallied</a> today after Moody\u2019s <a href=\"https://www.moodys.com/research/Moodys-Outlook-for-US-Coal-Industry-Changes-to-Stable-from--PR_279706\" target=\"_blank\">raised its coal industry outlook</a> to stable from negative, saying business conditions have hit bottom and it doesn't expect industry fundamentals to deteriorate further over the next 12-18  months.</li>     <li>\"Sustained natural gas prices will prop up demand for the thermal coal used in power production through mid-2014 to early 2015, while supply rationalization should help stabilize prices for metallurgical coal, which is used in steelmaking,\" the ratings agency says.</li>     <li>Surging today: <a href=\"https://seekingalpha.com/symbol/WLT\" title=\"Walter Energy, Inc.\">WLT</a> <font color=\"green\">+13.7%</font>, JRCC <font color=\"green\">+11.8%</font>, ANR <font color=\"green\">+11.4%</font>, <a href=\"https://seekingalpha.com/symbol/ACI\" title=\"Albertsons Companies Inc\">ACI</a> <font color=\"green\">+8.6%</font>, <a href=\"https://seekingalpha.com/symbol/BTU\" title=\"Peabody Energy Corp.\">BTU</a> <font color=\"green\">+7.8%</font>, <a href=\"https://seekingalpha.com/symbol/CNX\" title=\"CNX Resources Corporation\">CNX</a> <font color=\"green\">+4%</font>, <a href=\"https://seekingalpha.com/symbol/CLD\" title=\"Cloud Peak Energy, Inc.\">CLD</a> <font color=\"green\">+3.6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1213502\" data-linked=\"Coal stocks rally on improved Moody&#39;s outlook\" data-tweet=\"$WLT $KOL $WLT - Coal stocks rally on improved Moody&#39;s outlook https://seekingalpha.com/news/1213502-coal-stocks-rally-on-improved-moodys-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/1213502-coal-stocks-rally-on-improved-moodys-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1213442\" data-ts=\"1376083908\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1213442-after-hours-top-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After-hours top gainers/ Losers</a></h4><ul>     <li><b>After-hours top gainers, as of 5:15 p.m.:</b> <a href='https://seekingalpha.com/symbol/AGO' title='Assured Guaranty Ltd.'>AGO</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/CVT' title='Cvent, Inc.'>CVT</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/ASTX' title='Astex Pharmaceuticals, Inc.'>ASTX</a> <font color='green'>+5%</font>. CADX <font color='green'>+4%</font>. <a href='https://seekingalpha.com/symbol/AKS' title='AK Steel Holding Corp'>AKS</a> <font color='green'>+3%</font>.</li><li><b>After-hours top losers:</b> <a href='https://seekingalpha.com/symbol/BIOS' title='BioScrip, Inc.'>BIOS</a> <font color='red'>-3%</font>. <a href='https://seekingalpha.com/symbol/ZOLT' title='Zoltek Companies, Inc.'>ZOLT</a> <font color='red'>-2%</font>. WWWW <font color='red'>-2%</font>. <a href='https://seekingalpha.com/symbol/MNKD' title='MannKind Corporation'>MNKD</a> <font color='red'>-2%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1213442\" data-linked=\"After-hours top gainers/ Losers\" data-tweet=\"$AGO $CVT $ASTX - After-hours top gainers/ Losers https://seekingalpha.com/news/1213442-after-hours-top-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/1213442-after-hours-top-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1213422\" data-ts=\"1376083027\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1213422-the-weeks-etf-movers-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">The week&#39;s ETF movers - Gainers / Losers</a></h4><ul>     <li> <b>The week's ETF movers - Gainers:</b> <a href=\"https://seekingalpha.com/symbol/gdxj\" title=\"Market Vectors Junior Gold Miners ETF\">GDXJ</a> <font color=\"green\">+6.13%</font>. <a href=\"https://seekingalpha.com/symbol/kol\" title=\"Market Vectors Coal ETF\">KOL</a> <font color=\"green\">+3.76%</font>. <a href=\"https://seekingalpha.com/symbol/pslv\" title=\"Sprott Physical Silver Trust\">PSLV</a> <font color=\"green\">+3.69%</font>. <a href=\"https://seekingalpha.com/symbol/gdx\" title=\"Market Vectors Gold Miners ETF\">GDX</a> <font color=\"green\">+3.44%</font>. <a href=\"https://seekingalpha.com/symbol/slv\" title=\"iShares Silver Trust ETF\">SLV</a> <font color=\"green\">+3.35%</font>.  </li>\n<li> <b>ETF Losers:</b> <a href=\"https://seekingalpha.com/symbol/xhb\" title=\"SPDR Homebuilders ETF\">XHB</a> <font color=\"red\">-4.12%</font>. <a href=\"https://seekingalpha.com/symbol/ung\" title=\"The United States Natural Gas ETF, LP\">UNG</a> <font color=\"red\">-3.56%</font>. <a href=\"https://seekingalpha.com/symbol/gaz\" title=\"iPath DJ-UBS Natural Gas Total Return Sub-Index ETN\">GAZ</a> <font color=\"red\">-3.07%</font>. <a href=\"https://seekingalpha.com/symbol/vnm\" title=\"Market Vectors Vietnam ETF\">VNM</a> <font color=\"red\">-2.13%</font>. <a href=\"https://seekingalpha.com/symbol/ewy\" title=\"iShares MSCI South Korea Capped ETF\">EWY</a> <font color=\"red\">-2.10%</font>. </li> </ul><div class=\"tiny-share-widget\" data-id=\"1213422\" data-linked=\"The week&#39;s ETF movers - Gainers / Losers\" data-tweet=\"$GDXJ $KOL $PSLV - The week&#39;s ETF movers - Gainers / Losers https://seekingalpha.com/news/1213422-the-weeks-etf-movers-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/1213422-the-weeks-etf-movers-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1213292\" data-ts=\"1376080389\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MACK\" target=\"_blank\">MACK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1213292-merrimack-pharmaceuticals-misses-on-q2-eps-moves-up-on-back-of-sa-blog\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Merrimack Pharmaceuticals misses on Q2 EPS; moves up on back of SA blog</a></h4><ul>\n<li>Merrimack Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/MACK\" title=\"Merrimack Pharmaceuticals\">MACK</a> <font color=\"green\">+10.4%</font>) finishes higher today, despite posting a Q2 net loss of $0.31 per share, missing estimates by $0.03.</li>\n<li>Collaboration revenues were $12.063M , also down versus a year ago.</li>\n<li>Perhaps today's strength can be attributed to an upbeat <a href=\"https://seekingalpha.com/article/1622272-tekla-capital-management-has-been-accumulating-shares-of-merrimack-pharmaceuticals\" target=\"_blank\">SA post</a> reporting Tekla Capital Management has bought 537,600 shares since the beginning of the year, 353,400 shares in Q2 alone.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1213292\" data-linked=\"Merrimack Pharmaceuticals misses on Q2 EPS; moves up on back of SA blog\" data-tweet=\"$MACK - Merrimack Pharmaceuticals misses on Q2 EPS; moves up on back of SA blog https://seekingalpha.com/news/1213292-merrimack-pharmaceuticals-misses-on-q2-eps-moves-up-on-back-of-sa-blog?source=tweet\" data-url=\"https://seekingalpha.com/news/1213292-merrimack-pharmaceuticals-misses-on-q2-eps-moves-up-on-back-of-sa-blog\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:33 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1213182\" data-ts=\"1376078918\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BGMD\" target=\"_blank\">BGMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1213182-bg-medical-cut-to-neutral-at-baird-shares-finish-lower\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BG Medical cut to Neutral at Baird; shares finish lower</a></h4><ul>\n<li>BG Medical (<a href=\"https://seekingalpha.com/symbol/BGMD\" title=\"BG Medicine, Inc.\">OTC:BGMD</a> <font color=\"red\">-13.4%</font>) finishes the day markedly lower after Baird <a href=\"http://www.streetinsider.com/Downgrades/Baird+Downgrades+BG+Medicine+%28BGMD%29+to+Neutral/8585660.html\" target=\"_blank\">cut the shares</a> to Neutral this morning and reduced its price target to $1 from $3.</li>\n<li>The downgrade follows the company's <a href=\"https://seekingalpha.com/market_currents/post/1207612\" target=\"_blank\">Q2 earnings</a> report released Thursday, showing that revenue grew 62% Y/Y, but missed expectations.</li>\n<li>The firm says new management is taking the appropriate actions to refocus the company on better near-term opportunities, but H2 looks to be well below consensus, as commercial traction has been slow, near-term opportunities are heavily dependent on external parties, and financial flexibility becomes more limited.</li>\n<li>Baird suggests moving to the sidelines, and waiting for signs that a more meaningful revenue ramp is materializing.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1213182\" data-linked=\"BG Medical cut to Neutral at Baird; shares finish lower\" data-tweet=\"$BGMD - BG Medical cut to Neutral at Baird; shares finish lower https://seekingalpha.com/news/1213182-bg-medical-cut-to-neutral-at-baird-shares-finish-lower?source=tweet\" data-url=\"https://seekingalpha.com/news/1213182-bg-medical-cut-to-neutral-at-baird-shares-finish-lower\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1213122\" data-ts=\"1376078052\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARCB\" target=\"_blank\">ARCB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1213122-arkansas-best-jumps-after-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Arkansas Best jumps after Q2 results</a></h4><ul>     <li>Shares of Arkansas Best (ABFS <font color=\"green\">+16.6%</font>) are having a banner day on the heels of the company's Q2 report.</li>     <li>Revenue was up 13% Y/Y during the period to $576.9M, beating estimates.</li>     <li>Q2 EPS of $0.18 looks optically worse than the $0.44/ share profit the company posted in Q2 2012. However, a tax benefit was largely responsible for last year's Q2 EPS figure. Strip that out and add back a $0.05/ share charge associated with the Panther acquisition and you get $0.18, exactly the same as this quarter's figure. (PR)</li>     <li>The company notes that the ratification of the ABF National Master Freight Agreement is a \"major step toward returning the company to consistent profitability.\" (<a href=\"https://seekingalpha.com/currents/post/1112412\" target=\"_blank\">previous</a>)</li> </ul><div class=\"tiny-share-widget\" data-id=\"1213122\" data-linked=\"Arkansas Best jumps after Q2 results\" data-tweet=\"$ARCB - Arkansas Best jumps after Q2 results https://seekingalpha.com/news/1213122-arkansas-best-jumps-after-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/1213122-arkansas-best-jumps-after-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:54 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1213102\" data-ts=\"1376077325\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GNVC\" target=\"_blank\">GNVC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1213102-genvec-votes-to-dissolve-company\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GenVec votes to dissolve company</a></h4><ul>\n<li>GenVec (<a href=\"https://seekingalpha.com/symbol/GNVC\" title=\"GenVec, Inc.\">GNVC</a> <font color=\"red\">-20%</font>) tanks <a href=\"http://www.sec.gov/Archives/edgar/data/934473/000114420413044076/v352305_prem14a.htm\" target=\"_blank\">after disclosing</a> that it's unanimously agreed that dissolving the firm was in its best interests, concluding any of the other proposed transactions were at best, \"extremely risky.\"</li>\n<li>The resolution still requires shareholder approval before being forwarded to the Delaware Secretary of State.</li>\n<li>The company estimates it will incur about $311,785 in costs as a result of <a href=\"https://seekingalpha.com/market_currents/post/1115762\" target=\"_blank\">employee layoffs</a>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1213102\" data-linked=\"GenVec votes to dissolve company\" data-tweet=\"$GNVC - GenVec votes to dissolve company https://seekingalpha.com/news/1213102-genvec-votes-to-dissolve-company?source=tweet\" data-url=\"https://seekingalpha.com/news/1213102-genvec-votes-to-dissolve-company\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:42 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1213082\" data-ts=\"1376076669\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AIRM\" target=\"_blank\">AIRM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1213082-air-methods-surges-14-percent-as-q2-miss-attributed-to-weather\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Air Methods surges 14% as Q2 miss attributed to weather</a></h4><ul>     <li>Although Air Methods' (<a href=\"https://seekingalpha.com/symbol/AIRM\" title=\"Air Methods Corporation\">AIRM</a> <font color=\"green\">+14.5%</font>) <a href=\"https://seekingalpha.com/currents/post/1209682\" target=\"_blank\">Q2 results</a> missed analyst estimates, Oppenheimer says \"all indications point to a very strong rebound in [H2], as lower maintenance, improved weather, a rebound in payor mix and stronger pricing should act as catalysts going forward.\"</li>     <li>AIRM attributes decreases in June and July flight volumes to higher weather cancellations, but Q2 brought a return to growth in net revenue per patient transport,  while days' sales outstanding decreased from 128 days as of March 31 to 99 days as of  June 30.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1213082\" data-linked=\"Air Methods surges 14% as Q2 miss attributed to weather\" data-tweet=\"$AIRM - Air Methods surges 14% as Q2 miss attributed to weather https://seekingalpha.com/news/1213082-air-methods-surges-14-percent-as-q2-miss-attributed-to-weather?source=tweet\" data-url=\"https://seekingalpha.com/news/1213082-air-methods-surges-14-percent-as-q2-miss-attributed-to-weather\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1213072\" data-ts=\"1376076628\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PMC\" target=\"_blank\">PMC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1213072-pharmerica-charged-by-justice-department-for-violating-controlled-substances-act-filing-false-medicare-claims\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pharmerica charged by Justice Department for violating Controlled Substances Act; filing false Medicare claims</a></h4><ul>\n<li>The Justice Department has <a href=\"http://www.justice.gov/opa/pr/2013/August/13-civ-903.html\" target=\"_blank\">filed suit</a> against PharMerica (<a href=\"https://seekingalpha.com/symbol/PMC\" title=\"PharMerica Corporation\">PMC</a> <font color=\"red\">-6%</font>) claiming it violated the False Claims Act and the Controlled Substances Act by dispensing controlled drugs without valid prescriptions and causing claims for illegally dispensed drugs to be submitted to the  Medicare  program.</li>\n<li>The complaint alleges that <a href=\"https://seekingalpha.com/symbol/PMC\" title=\"PharMerica Corporation\">PMC</a> routinely dispensed Schedule II controlled drugs in non-emergency situations without first obtaining a written prescription from a treating physician, then knowingly submitted false claims to Medicare for the improperly dispensed Schedule II drugs.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1213072\" data-linked=\"Pharmerica charged by Justice Department for violating Controlled Substances Act; filing false Medicare claims\" data-tweet=\"$PMC - Pharmerica charged by Justice Department for violating Controlled Substances Act; filing false Medicare claims https://seekingalpha.com/news/1213072-pharmerica-charged-by-justice-department-for-violating-controlled-substances-act-filing-false-medicare-claims?source=tweet\" data-url=\"https://seekingalpha.com/news/1213072-pharmerica-charged-by-justice-department-for-violating-controlled-substances-act-filing-false-medicare-claims\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:30 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1213062\" data-ts=\"1376076017\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GTIV\" target=\"_blank\">GTIV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1213062-amedisys-news-propels-gentiva-health-sharply-higher\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amedisys news propels Gentiva Health sharply higher</a></h4><ul><li>News that KKR has <a href=\"https://seekingalpha.com/currents/post/1212582\" target=\"_blank\">taken an 8.5% stake</a> in Amedisys looks to be fueling a rally in shares of competitor Gentiva Health Systems (<a href='https://seekingalpha.com/symbol/GTIV' title='Gentiva Health Services, Inc.'>GTIV</a> <font color='green'>+17.3%</font>). The stock has traded sharply higher throughout the session. <br></li></ul><div class=\"tiny-share-widget\" data-id=\"1213062\" data-linked=\"Amedisys news propels Gentiva Health sharply higher\" data-tweet=\"$GTIV - Amedisys news propels Gentiva Health sharply higher https://seekingalpha.com/news/1213062-amedisys-news-propels-gentiva-health-sharply-higher?source=tweet\" data-url=\"https://seekingalpha.com/news/1213062-amedisys-news-propels-gentiva-health-sharply-higher\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:20 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1213052\" data-ts=\"1376075796\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CZR\" target=\"_blank\">CZR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1213052-caesars-entertainment-selling-macau-property\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Caesars Entertainment selling Macau property</a></h4><ul>     <li>Caesars Entertainment (<a href=\"https://seekingalpha.com/symbol/CZR\" title=\"Caesars Entertainment\">CZR</a> <font color=\"green\">+4.3%</font>) hits a 52-week high after disclosing it is <a href=\"http://www.sec.gov/Archives/edgar/data/858339/000085833913000048/a2013q2form10-q.htm\" target=\"_blank\">selling its property in Macau</a> to Asian developer Pearl Dynasty for $438M.</li>     <li>The sale price is well shy of the $578M corporate predecessor Harrah's paid for the property in 2007, but CZR was unable to secure a license to build a casino on the property.</li>     <li>CZR also has been enjoying a boost on talk that Nevada and New Jersey are <a href=\"http://news.investors.com/business/080913-667000-caesars-mgm-resorts-melco-crown-shares-rack-up-wins.htm\" target=\"_blank\">working on an online gambling compact</a>, a potential step closer to legal, national online gaming.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1213052\" data-linked=\"Caesars Entertainment selling Macau property\" data-tweet=\"$CZR - Caesars Entertainment selling Macau property https://seekingalpha.com/news/1213052-caesars-entertainment-selling-macau-property?source=tweet\" data-url=\"https://seekingalpha.com/news/1213052-caesars-entertainment-selling-macau-property\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:16 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1213032\" data-ts=\"1376074774\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLF\" target=\"_blank\">CLF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1213032-global-cyclicals-extend-gains-on-chinese-industrial-growth\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Global cyclicals extend gains on Chinese industrial growth</a></h4><ul>     <li>Cliffs Natural Resources (<a href='https://seekingalpha.com/symbol/CLF' title='Cleveland-Cliffs, Inc.'>CLF</a> <font color='green'>+10.6%</font>) and other heavy global cyclical stocks are among the day's strongest performers, adding to <a href=\"https://seekingalpha.com/currents/post/1208302\" target=\"_blank\">yesterday's gains</a> sparked by <a href=\"https://seekingalpha.com/currents/post/1210722\" target=\"_blank\">Chinese industrial growth</a>.</li>     <li><a href='https://seekingalpha.com/symbol/BTU' title='Peabody Energy Corp.'>BTU</a> <font color='green'>+8.1%</font>, <a href='https://seekingalpha.com/symbol/RIO' title='Rio Tinto plc'>RIO</a> <font color='green'>+6%</font>, <a href='https://seekingalpha.com/symbol/BHP' title='BHP Billiton Limited'>BHP</a> <font color='green'>+3.1%</font>, <a href='https://seekingalpha.com/symbol/X' title='United States Steel Corporation'>X</a> <font color='green'>+4.9%</font>, <a href='https://seekingalpha.com/symbol/MT' title='ArcelorMittal'>MT</a> <font color='green'>+6.2%</font>, <a href='https://seekingalpha.com/symbol/NUE' title='Nucor Corporation'>NUE</a> <font color='green'>+4.5%</font>, <a href='https://seekingalpha.com/symbol/VALE' title='Vale S.A.'>VALE</a> <font color='green'>+5.8%</font> <a href='https://seekingalpha.com/symbol/FCX' title='Freeport-McMoRan Inc.'>FCX</a> <font color='green'>+3.4%</font>, <a href='https://seekingalpha.com/symbol/SCCO' title='Southern Copper Corporation'>SCCO</a> <font color='green'>+4%</font>, <a href='https://seekingalpha.com/symbol/JOY' title='Joy Global Inc.'>JOY</a> <font color='green'>+3.4%</font>, <a href='https://seekingalpha.com/symbol/CAT' title='Caterpillar Inc.'>CAT</a> <font color='green'>+0.8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1213032\" data-linked=\"Global cyclicals extend gains on Chinese industrial growth\" data-tweet=\"$CLF $CLF $BTU - Global cyclicals extend gains on Chinese industrial growth https://seekingalpha.com/news/1213032-global-cyclicals-extend-gains-on-chinese-industrial-growth?source=tweet\" data-url=\"https://seekingalpha.com/news/1213032-global-cyclicals-extend-gains-on-chinese-industrial-growth\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1212982\" data-ts=\"1376073774\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NDLS\" target=\"_blank\">NDLS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1212982-noodles-shares-slip-after-underwhelming-forecast\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Noodles shares slip after underwhelming forecast</a></h4><ul>     <li>Noodles &amp; Co.'s (<a href=\"https://seekingalpha.com/symbol/NDLS\" title=\"Noodles &amp; Company\">NDLS</a> <font color=\"red\">-9.9%</font>) first results since debuting on the market <a href=\"https://seekingalpha.com/currents/post/1209402\" target=\"_blank\">beat estimates</a> but the company eked out only a small profit, which slumped 97% Y/Y, weighed by expenses tied to the IPO.</li>     <li>NDLS guided FY 2013 EPS to $0.39-$0.41 vs. $0.31 in 2012, in-line with analysts' estimates of $0.40 but investors apparently expected more; expectations of a 3% rise in sales at established restaurants would be a slowdown from Q2's 4.4% gain.</li>\n<li>Stifel Nicolaus says investors have <a href=\"http://finance.yahoo.com/news/noodles-co-shares-fall-forecast-162150569.html\" target=\"_blank\">overvalued NDLS  growth prospects</a>; the firm expects shares to trade more in line  with the market over the next year.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1212982\" data-linked=\"Noodles shares slip after underwhelming forecast\" data-tweet=\"$NDLS - Noodles shares slip after underwhelming forecast https://seekingalpha.com/news/1212982-noodles-shares-slip-after-underwhelming-forecast?source=tweet\" data-url=\"https://seekingalpha.com/news/1212982-noodles-shares-slip-after-underwhelming-forecast\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:42 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1212952\" data-ts=\"1376073383\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YONG\" target=\"_blank\">YONG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1212952-yongye-international-jumps-on-q2-reuslts\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Yongye International jumps on Q2 reuslts</a></h4><ul>\n<li>Shares of Yongye International (<a href=\"https://seekingalpha.com/symbol/YONG\" title=\"Yongye International Inc\">YONG</a> <font color=\"green\">+9.9%</font>) are among today's winners after the Chinese agricultural nutrient company reported Q2 results.</li>\n<li>Revenue for the period was $301.3M, up nearly 70% from Q2 2012.</li>\n<li>Q2 adjusted EPS came in at $1.51, which looks pretty good compared to $0.74/ share in the same period last year.</li>\n<li>No decision has been made on a response to a going private proposal.</li>\n<li>Outlook: FY13 total shipments of $650-680M. (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1212952\" data-linked=\"Yongye International jumps on Q2 reuslts\" data-tweet=\"$YONG - Yongye International jumps on Q2 reuslts https://seekingalpha.com/news/1212952-yongye-international-jumps-on-q2-reuslts?source=tweet\" data-url=\"https://seekingalpha.com/news/1212952-yongye-international-jumps-on-q2-reuslts\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:36 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1212912\" data-ts=\"1376072561\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GPS\" target=\"_blank\">GPS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1212912-gap-minus-3-percent-after-disappointing-same-store-sales-analyst-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gap -3% after disappointing same-store sales, analyst downgrade</a></h4><ul>     <li>Investors focus on Gap's (<a href=\"https://seekingalpha.com/symbol/GPS\" title=\"The Gap, Inc.\">GPS</a> <font color=\"red\">-2.9%</font>) below-consensus <a href=\"https://seekingalpha.com/currents/post/1209672\" target=\"_blank\">1% increase in July same-store sales</a> rather than upside Q2 guidance, sending shares sharply lower.</li>\n<li>Analysts generally are <a href=\"http://blogs.barrons.com/stockstowatchtoday/2013/08/09/the-gaps-gap-shares-fall-3-on-disappointing-sales-susquehanna-downgrade/\" target=\"_blank\">more positive</a> than the market; Janney blames sputtering sales on difficult comparisons, remains encouraged by solid traffic trends across all divisions, and expects sustainable positive comps going forward.</li>\n<li>Even a <a href=\"http://finance.yahoo.com/news/gap-shares-fall-analyst-downgrade-154857026.html\" target=\"_blank\">downgrade</a> to Neutral at Susquehanna is based entirely on valuation; the firm says Q2 was \"another well executed quarter\" and \"applaud[s] management\u2019s execution of the business, distribution of excess cash to shareholders and focus on building an omni-channel global presence.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"1212912\" data-linked=\"Gap -3% after disappointing same-store sales, analyst downgrade\" data-tweet=\"$GPS - Gap -3% after disappointing same-store sales, analyst downgrade https://seekingalpha.com/news/1212912-gap-minus-3-percent-after-disappointing-same-store-sales-analyst-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/1212912-gap-minus-3-percent-after-disappointing-same-store-sales-analyst-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:22 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1212892\" data-ts=\"1376072117\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CFN\" target=\"_blank\">CFN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1212892-carefusion-drifts-lower-on-an-fq4-earnings-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Carefusion drifts lower on an FQ4 earnings miss</a></h4><ul>\n<li>CareFusion (<a href=\"https://seekingalpha.com/symbol/CFN\" title=\"CareFusion Corporation\">CFN</a> <font color=\"red\">-0.4%</font>) dips into the red today after its <a href=\"https://seekingalpha.com/market_currents/post/1209962\" target=\"_blank\">FQ4 missed estimates</a> across the board.</li>\n<li>Net earnings increased 14% Y/Y as margins improved and overhead expenses decreased.</li>\n<li>Procedural-solutions segment revenue jumped 7.2% to $311M, with gains across all business lines, but medical-systems revenue fell 12% over the same period to $592M.</li>\n<li>For the new year, the company sees its EPS coming in between $2.30 to $2.40 on revenue growth of 1% to 4%, bracketing Street estimates of $2.36 per share and revenue growth of 3%.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1212892\" data-linked=\"Carefusion drifts lower on an FQ4 earnings miss\" data-tweet=\"$CFN - Carefusion drifts lower on an FQ4 earnings miss https://seekingalpha.com/news/1212892-carefusion-drifts-lower-on-an-fq4-earnings-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/1212892-carefusion-drifts-lower-on-an-fq4-earnings-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:15 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1212882\" data-ts=\"1376072071\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MNST\" target=\"_blank\">MNST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1212882-goldman-isnt-afraid-of-the-monster-after-choppy-quarter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goldman isn&#39;t afraid of the Monster after &quot;choppy&quot; quarter</a></h4><ul>\n<li>Goldman is <a href=\"http://www.streetinsider.com/Analyst+Comments/Monster+Beverage+%28MNST%29+Positive+Thesis+Intact+Despite+Choppy+Q2/8586497.html\" target=\"_blank\">still positive</a> on Buy-rated Monster Beverage (<a href=\"https://seekingalpha.com/symbol/MNST\" title=\"Monster Beverage Corp.\">MNST</a> <font color=\"green\">+1.9%</font>) following a Q2 miss, and apparently so are investors as the stock trades higher after showing some weakness in Thursday's post-session.</li>\n<li>Analyst Judy Hong says the \"core tenets\" of the company's story (U.S. sales recovery, international growth, higher international profits) remain largely intact.</li>\n<li>Hong got some clarity from management on the conference call regarding the pipe lap in Japan and excluding that, she thinks \"underlying sales are running close to +10%.\"</li>\n<li>Goldman's price target is $70.</li>\n<li>Read Hong's Q&amp;A with management on the <a href=\"https://seekingalpha.com/article/1621872-monster-beverage-management-discusses-q2-2013-results-earnings-call-transcript\" target=\"_blank\">CC transcript</a>\n</li>\n<li><a href=\"https://seekingalpha.com/currents/post/1209892\" target=\"_blank\">Earnings summary</a></li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1212882\" data-linked=\"Goldman isn&#39;t afraid of the Monster after &quot;choppy&quot; quarter\" data-tweet=\"$MNST - Goldman isn&#39;t afraid of the Monster after &quot;choppy&quot; quarter https://seekingalpha.com/news/1212882-goldman-isnt-afraid-of-the-monster-after-choppy-quarter?source=tweet\" data-url=\"https://seekingalpha.com/news/1212882-goldman-isnt-afraid-of-the-monster-after-choppy-quarter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:14 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1212862\" data-ts=\"1376071940\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ENTR\" target=\"_blank\">ENTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1212862-entropic-higher-after-ceo-discloses-10k-share-purchase\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Entropic higher after CEO discloses 10K-share purchase</a></h4><ul>\n<li>Entropic (<a href=\"https://seekingalpha.com/symbol/ENTR\" title=\"Entropic Communications, Inc.\">ENTR</a> <font color=\"green\">+3.3%</font>) CEO Patrick Henry discloses he bought 10K shares on Thursday at $3.67. (<a href=\"http://www.sec.gov/Archives/edgar/data/1227930/000141760613000063/xslF345/edgardoc.xml\" target=\"_blank\">Form 4</a>)</li>\n<li>The vote of confidence comes with Entropic shares <a href=\"https://www.google.com/finance?chdnp=1&amp;chdd=1&amp;chds=1&amp;chdv=1&amp;chvs=maximized&amp;chdeh=0&amp;chfdeh=0&amp;chdet=1375819200000&amp;chddm=266139&amp;chls=IntervalBasedLine&amp;q=NASDAQ:ENTR&amp;ntsp=1&amp;ei=Ay4FUqiTEaKgiAL18wE\" target=\"_blank\">close to multi-year lows </a>thanks to the <a href=\"https://seekingalpha.com/currents/post/1186192\" target=\"_blank\">dismal Q3 guidance</a> provided by the chipmaker last week.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1212862\" data-linked=\"Entropic higher after CEO discloses 10K-share purchase\" data-tweet=\"$ENTR - Entropic higher after CEO discloses 10K-share purchase https://seekingalpha.com/news/1212862-entropic-higher-after-ceo-discloses-10k-share-purchase?source=tweet\" data-url=\"https://seekingalpha.com/news/1212862-entropic-higher-after-ceo-discloses-10k-share-purchase\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:12 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1212662\" data-ts=\"1376071606\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ECOM\" target=\"_blank\">ECOM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1212662-channeladvisor-up-second-day-in-a-row-after-q2-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ChannelAdvisor up second day in a row after Q2 beat</a></h4><ul>     <li>ChannelAdvisor (<a href=\"https://seekingalpha.com/symbol/ECOM\" title=\"ChannelAdvisor Corp\">ECOM</a> <font color=\"green\">+4.3%</font>) is up for the second consecutive day after the company <a href=\"https://seekingalpha.com/currents/post/1204642\" target=\"_blank\">handily beat</a> Q2 estimates, and provided strong full-year guidance. The stock is <strong><font color=\"green\">up 25%</font></strong> since Wednesday, and 77% from its May IPO price of $14.</li>\n<li>\n<a href=\"https://seekingalpha.com/currents/post/1133702\" target=\"_blank\">Previous</a>: ChannelAdvisor reported strong same-store sales growth for clients selling via Amazon and eBay in June, and also did so for the 2 previous months.</li>     <li> <a href=\"http://blog.channeladvisor.com/\" target=\"_blank\">On deck</a>: July client same-store sales results</li> </ul><div class=\"tiny-share-widget\" data-id=\"1212662\" data-linked=\"ChannelAdvisor up second day in a row after Q2 beat\" data-tweet=\"$ECOM - ChannelAdvisor up second day in a row after Q2 beat https://seekingalpha.com/news/1212662-channeladvisor-up-second-day-in-a-row-after-q2-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/1212662-channeladvisor-up-second-day-in-a-row-after-q2-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:06 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1212852\" data-ts=\"1376071507\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NOAH\" target=\"_blank\">NOAH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1212852-noah-skyrockets-after-raising-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Noah skyrockets after raising guidance</a></h4><ul>     <li>Noah Holdings (<a href=\"https://seekingalpha.com/symbol/NOAH\" title=\"Noah Holdings Limited\">NOAH</a> <font color=\"green\">+25.3%</font>) shares skyrocket after the Chinese money manager lifted its full-year earnings outlook, saying business has grown faster than expected.</li>     <li>NOAH raised net income guidance by ~50% to $50M-$55M from $33M-$37M and now  anticipates 86-105% Y/Y growth, driven mostly by its Gopher asset management business.</li>     <li>Oppenheimer <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/13/08/3827152/update-oppenheimer-upgrades-noah-holdings-on-guidance\" target=\"_blank\">upgrades</a> shares to Outperform with an $18 price target, as robust Gopher growth more than offsets the uncertainties at the traditional distribution business.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1212852\" data-linked=\"Noah skyrockets after raising guidance\" data-tweet=\"$NOAH - Noah skyrockets after raising guidance https://seekingalpha.com/news/1212852-noah-skyrockets-after-raising-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/1212852-noah-skyrockets-after-raising-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:05 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1212832\" data-ts=\"1376071048\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZOLT\" target=\"_blank\">ZOLT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1212832-zoltek-rumored-to-have-receive-takeover-approach\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zoltek rumored to have receive takeover approach</a></h4><ul>     <li>Shares of Zoltek (<a href=\"https://seekingalpha.com/symbol/ZOLT\" title=\"Zoltek Companies, Inc.\">ZOLT</a> <font color=\"red\">-1.2%</font>) get volatile on the back of a Financial Times report saying the carbon fiber composite maker is rumored to have <a href=\"http://ftalphaville.ft.com/2013/08/09/1598122/bidders-said-to-circle-zoltek/\" target=\"_blank\">received takeover approaches</a> at around $22 per share, which would value the company at about $800M.</li>     <li>Quinpario Acquisition Corp., a blank check acquisition firm, coincidentally <a href=\"http://www.nasdaq.com/article/spac-quinpario-acquisition-prices-ipo-at-10-raising-150-million-cm266231\" target=\"_blank\">priced its IPO</a> at $10 and begins trading on the Nasdaq Exchange today under the symbol \"QPACU,\" is the leading suitor.</li>     <li>In March, Quinpario had an <a href=\"https://seekingalpha.com/market_currents/post/921881\" target=\"_blank\">offer rejected</a> to buy Zoltek for a price in the mid teens.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1212832\" data-linked=\"Zoltek rumored to have receive takeover approach\" data-tweet=\"$ZOLT - Zoltek rumored to have receive takeover approach https://seekingalpha.com/news/1212832-zoltek-rumored-to-have-receive-takeover-approach?source=tweet\" data-url=\"https://seekingalpha.com/news/1212832-zoltek-rumored-to-have-receive-takeover-approach\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:57 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1212822\" data-ts=\"1376070488\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NKTR\" target=\"_blank\">NKTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1212822-nektar-and-astrazeneca-amend-naloxegol-agreement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nektar and AstraZeneca amend naloxegol agreement</a></h4><ul>\n<li>Nektar Therapeutics (<a href=\"https://seekingalpha.com/symbol/NKTR\" title=\"Nektar Therapeutics\">NKTR</a> <font color=\"green\">+12.1%</font>) is flying high today after posting a Q2 loss that wasn't as wide as analysts expected.</li>\n<li>Certainly worth a look is an <a href=\"http://www.sec.gov/Archives/edgar/data/906709/000114420413044002/v352405_8k.htm\" target=\"_blank\">8-K</a> filed yesterday which amends the terms of NKTR's naloxegol license agreement with AstraZeneca (<a href=\"https://seekingalpha.com/symbol/AZN\" title=\"AstraZeneca Group plc\">AZN</a> <font color=\"green\">+0.1%</font>).</li>\n<li>AZN will submit an NDA to the FDA and an MAA to the EMA next month. Acceptance of the NDA entitles NKTR to a $70M milestone payment within five days. Acceptance of the MAA wins NKTR $25M.</li>\n<li>If the FDA does not require a pre-approval CV study, NKTR is eligible for another $35M. <em>However</em>, if the regulator<em> does </em>require a CV study, AZN can terminate the agreement, in which case NKTR will have to pay $70M plus accrued interest in four installments.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1212822\" data-linked=\"Nektar and AstraZeneca amend naloxegol agreement\" data-tweet=\"$NKTR $NKTR $AZN - Nektar and AstraZeneca amend naloxegol agreement https://seekingalpha.com/news/1212822-nektar-and-astrazeneca-amend-naloxegol-agreement?source=tweet\" data-url=\"https://seekingalpha.com/news/1212822-nektar-and-astrazeneca-amend-naloxegol-agreement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:48 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1212812\" data-ts=\"1376070353\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVG\" target=\"_blank\">AVG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1212812-avg-slumps-following-block-trade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AVG slumps following block trade</a></h4><ul>\n<li>AVG (<a href=\"https://seekingalpha.com/symbol/AVG\" title=\"AVG Technologies\">AVG</a> <font color=\"red\">-4.5%</font>) is down to $21.56 after a 3.5M-share block trade was carried out this morning at $21.75, courtesy of Morgan Stanley.</li>\n<li>\n<a href=\"https://seekingalpha.com/currents/post/1190922\" target=\"_blank\">Shares dove</a> a week ago on account of the soft Q3 guidance provided with the company's <a href=\"https://seekingalpha.com/currents/post/1187372\" target=\"_blank\">Q2 results</a>, but had largely recouped their losses going into today.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1212812\" data-linked=\"AVG slumps following block trade\" data-tweet=\"$AVG - AVG slumps following block trade https://seekingalpha.com/news/1212812-avg-slumps-following-block-trade?source=tweet\" data-url=\"https://seekingalpha.com/news/1212812-avg-slumps-following-block-trade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1212802\" data-ts=\"1376070075\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AGO\" target=\"_blank\">AGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1212802-assured-guaranty-moves-higher-against-a-mixed-q2-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Assured Guaranty moves higher against a mixed Q2 report</a></h4><ul>\n<li>Assured Guaranty (<a href=\"https://seekingalpha.com/symbol/AGO\" title=\"Assured Guaranty Ltd.\">AGO</a> <font color=\"green\">+3.5%</font>) moves up despite posting a <a href=\"https://seekingalpha.com/market_currents/post/1210362\" target=\"_blank\">Q2 miss</a> on its EPS late yesterday.</li>\n<li>Net profit fell 42% Y/Y as the bond insurer reported a lower fair-value gain and a decrease in net earned premiums.</li>\n<li>The latest period included just $28M in non-credit unrealized fair value gains on credit derivatives, compared with a $160M fair-value gain in the year-ago quarter.</li>\n<li>Net investment slipped 7.9% to $93M.</li>\n<li>Net premiums earned fell 26% to $163M.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1212802\" data-linked=\"Assured Guaranty moves higher against a mixed Q2 report\" data-tweet=\"$AGO - Assured Guaranty moves higher against a mixed Q2 report https://seekingalpha.com/news/1212802-assured-guaranty-moves-higher-against-a-mixed-q2-report?source=tweet\" data-url=\"https://seekingalpha.com/news/1212802-assured-guaranty-moves-higher-against-a-mixed-q2-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:41 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1212792\" data-ts=\"1376069686\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QLIK\" target=\"_blank\">QLIK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1212792-qlik-tibco-rally-in-sympathy-with-tableau\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Qlik, Tibco rally in sympathy with Tableau</a></h4><ul>\n<li>Qlik (<a href=\"https://seekingalpha.com/symbol/QLIK\" title=\"Qlik Technologies Inc.\">QLIK</a> <font color=\"green\">+3.9%</font>) and Tibco (<a href=\"https://seekingalpha.com/symbol/TIBX\" title=\"TIBCO Software, Inc.\">TIBX</a> <font color=\"green\">+1.5%</font>) are trading higher after analytics/data visualization software rival Tableau (<a href=\"https://seekingalpha.com/symbol/DATA\" title=\"Tableau Software\">DATA</a> <font color=\"green\">+13.5%</font>) <a href=\"https://seekingalpha.com/currents/post/1209552\" target=\"_blank\">soundly beats</a> Q2 estimates, reports strong deal activity, and issues above-consensus <a href=\"https://seekingalpha.com/currents/post/1210002\" target=\"_blank\">Q3/2013 guidance</a>.</li>\n<li>UBS' <a href=\"http://www.streetinsider.com/Analyst+Comments/UBS+Raises+Target+on+Tableau+Software+%28DATA%29/8586265.html\" target=\"_blank\">Brent Thill</a> is raising his Tableau PT to $75 from $65. He notes Tableau's 1.5K new customers top the 1K Qlik reported for Q2, and argues the size of Microsoft's Excel installed base (~1B users) \"proves [Tableau] has a long way to go\" in its \"multi-year journey to disrupt the traditional [business intelligence software] space</li>\n<li>Qlik sold off following its July 25 <a href=\"https://seekingalpha.com/currents/post/1165232\" target=\"_blank\">Q2 report</a>, but subsequently rebounded, and is making new 52-week highs today.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1212792\" data-linked=\"Qlik, Tibco rally in sympathy with Tableau\" data-tweet=\"$QLIK $QLIK $TIBX - Qlik, Tibco rally in sympathy with Tableau https://seekingalpha.com/news/1212792-qlik-tibco-rally-in-sympathy-with-tableau?source=tweet\" data-url=\"https://seekingalpha.com/news/1212792-qlik-tibco-rally-in-sympathy-with-tableau\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:34 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1212782\" data-ts=\"1376069637\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JCP\" target=\"_blank\">JCP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1212782-j-c-penney-chairman-issues-statement-on-ackman-letter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">J.C. Penney Chairman issues statement on Ackman letter</a></h4><ul>     <li>J.C. Penney's (<a href=\"https://seekingalpha.com/symbol/JCP\" title=\"J.C. Penney Company Inc.\">JCP</a> <font color=\"red\">-6.3%</font>) Chairman issues a statement in response to Bill Ackman's <a href=\"https://seekingalpha.com/currents/search?query=ackman+j.c.+penney\" target=\"_blank\">second letter</a> to the board. Highlights are below.</li>     <li>The board is <a href=\"https://twitter.com/cnbc/status/365888303775485952\" target=\"_blank\">focused on stabilizing and rejuvenating</a> the business.</li>     <li>CEO search is being conducted at an appropriate pace.</li>     <li>Ackman's statements are \"inaccurate and counterproductive.\"</li>     <li>\n<b>Update 1:40</b>: Ackman responds to JCP's Chairman, telling  CNBC's Scott Wapner that Pershing Square's letter is \"entirely accurate\"  and saying he looks forward to meeting with the \"entire board.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"1212782\" data-linked=\"J.C. Penney Chairman issues statement on Ackman letter\" data-tweet=\"$JCP - J.C. Penney Chairman issues statement on Ackman letter https://seekingalpha.com/news/1212782-j-c-penney-chairman-issues-statement-on-ackman-letter?source=tweet\" data-url=\"https://seekingalpha.com/news/1212782-j-c-penney-chairman-issues-statement-on-ackman-letter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:33 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1212742\" data-ts=\"1376068955\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PGNX\" target=\"_blank\">PGNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1212742-progenix-slips-on-mixed-q2-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Progenix slips on mixed Q2, misses on revenue</a></h4><ul>\n<li>Progenix Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/PGNX\" title=\"Progenics Pharmaceuticals Inc.\">PGNX</a> <font color=\"red\">-1.2%</font>) slips after reporting a <a href=\"https://seekingalpha.com/market_currents/post/1211162\" target=\"_blank\">mixed Q2</a>, coming in-line on a per share basis but missing on revenue.</li>\n<li>Royalty income was $1.2M compared to $1.6M in Q212, largely based on net sales of Relistor.</li>\n<li>Relistor global net sales increased 2% Q/Q, but fell by 27% Y/Y.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1212742\" data-linked=\"Progenix slips on mixed Q2, misses on revenue\" data-tweet=\"$PGNX - Progenix slips on mixed Q2, misses on revenue https://seekingalpha.com/news/1212742-progenix-slips-on-mixed-q2-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/1212742-progenix-slips-on-mixed-q2-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:22 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1212732\" data-ts=\"1376068275\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JNPR\" target=\"_blank\">JNPR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1212732-juniper-discloses-sec-doj-bribery-investigations-shares-fall\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Juniper discloses SEC/DOJ bribery investigations, shares fall</a></h4><ul>\n<li>In its <a href=\"http://www.sec.gov/Archives/edgar/data/1043604/000104360413000072/jnpr-10q20130630.htm\" target=\"_blank\">Q2 10-Q</a>, Juniper (<a href=\"https://seekingalpha.com/symbol/JNPR\" title=\"Juniper Networks\">JNPR</a> <font color=\"red\">-5%</font>) discloses the SEC and DOJ are \"conducting investigations into possible violations by the Company of the U.S. Foreign Corrupt Practices Act.\"</li>\n<li>Juniper says it's cooperating. However, <a href=\"http://www.bloomberg.com/news/2013-08-09/juniper-falls-after-disclosing-foreign-practices-investigations.html\" target=\"_blank\">a spokesman adds</a> the company \"can't predict the scope or duration\" of the probes.</li>\n<li>\n<a href=\"https://seekingalpha.com/currents/post/997531\" target=\"_blank\">IBM</a> and <a href=\"https://seekingalpha.com/currents/post/897371\" target=\"_blank\">Microsoft</a> are contending with similar investigations.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1212732\" data-linked=\"Juniper discloses SEC/DOJ bribery investigations, shares fall\" data-tweet=\"$JNPR - Juniper discloses SEC/DOJ bribery investigations, shares fall https://seekingalpha.com/news/1212732-juniper-discloses-sec-doj-bribery-investigations-shares-fall?source=tweet\" data-url=\"https://seekingalpha.com/news/1212732-juniper-discloses-sec-doj-bribery-investigations-shares-fall\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:11 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1212722\" data-ts=\"1376067676\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BB\" target=\"_blank\">BB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1212722-blackberry-pares-gains-a-bit-analysts-skeptical-buyout-will-happen\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BlackBerry pares gains a bit; analysts skeptical buyout will happen</a></h4><ul>\n<li>Though still up sharply, BlackBerry (BBRY <font color=\"green\">+6.4%</font>) is below its <a href=\"https://seekingalpha.com/currents/post/1211132\" target=\"_blank\">premarket highs</a>, as analysts question the odds the company will actually be taken private and/or doubt a major premium will be paid.</li>\n<li>\n<a href=\"http://www.marketwatch.com/story/blackberry-going-private-not-likely-says-analyst-2013-08-09\" target=\"_blank\">BGC:</a> \"Never say never but my read on this is this is just talk. ... You have to be highly skeptical of anonymous sources when there are no sources of capital.\"</li>\n<li>\n<a href=\"https://twitter.com/thenotablecalls/status/365842092557213698\" target=\"_blank\">MKM: </a>\"If it were to happen, however, we think it\u2019s more likely to be a take-under than a deal with a meaningful premium.\"</li>\n<li>\n<a href=\"http://blogs.barrons.com/techtraderdaily/2013/08/09/blackberry-buyout-or-no-need-to-cut-costs-says-wells/\" target=\"_blank\">Wells Fargo</a> argues BlackBerry doesn't need to go private if it's willing to adjust its cost structure \"to the reality of being a much-smaller revenue-generating entity.\" The firm points out BlackBerry spent 18.8% of its revenue on SG&amp;A over the last 4 quarters (compared with 13.2% of Nokia's phone unit and 6.3% for Apple), and 12.9% on R&amp;D (Nokia's phone unit was at 11.3%, and Apple at 2.5%).</li>\n<li>\n<a href=\"https://seekingalpha.com/currents/post/1210702\" target=\"_blank\">Previous</a>: BlackBerry reportedly open to going private</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1212722\" data-linked=\"BlackBerry pares gains a bit; analysts skeptical buyout will happen\" data-tweet=\"$BB - BlackBerry pares gains a bit; analysts skeptical buyout will happen https://seekingalpha.com/news/1212722-blackberry-pares-gains-a-bit-analysts-skeptical-buyout-will-happen?source=tweet\" data-url=\"https://seekingalpha.com/news/1212722-blackberry-pares-gains-a-bit-analysts-skeptical-buyout-will-happen\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1212702\" data-ts=\"1376067304\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HZNP\" target=\"_blank\">HZNP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1212702-horizon-pharma-slides-despite-posting-a-solid-q2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Horizon Pharma slides despite posting a solid Q2</a></h4><ul>\n<li>Horizon Pharma (<a href=\"https://seekingalpha.com/symbol/HZNP\" title=\"Horizon Pharma plc\">HZNP</a> <font color=\"red\">-5%</font>) slips today, despite reporting a <a href=\"https://seekingalpha.com/market_currents/post/1211082\" target=\"_blank\">solid Q2</a>.</li>\n<li>Gross and net sales rose 64% and 34% respectively Q/Q.</li>\n<li>Cash and cash equivalents as of June 30 total $69.3M, versus $81.1M at the end of March.</li>\n<li>Total DUEXIS pills dispensed in Q2 increased 9.3% versus Q1, as a result of longer initial prescriptions and a 3.7% Q/Q increase in refill rates.</li>\n<li>Gross-to-net sales deduction for DUEXIS was 33.1% versus 20.6% in Q1.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1212702\" data-linked=\"Horizon Pharma slides despite posting a solid Q2\" data-tweet=\"$HZNP - Horizon Pharma slides despite posting a solid Q2 https://seekingalpha.com/news/1212702-horizon-pharma-slides-despite-posting-a-solid-q2?source=tweet\" data-url=\"https://seekingalpha.com/news/1212702-horizon-pharma-slides-despite-posting-a-solid-q2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:55 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1212692\" data-ts=\"1376067161\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MHRCQ\" target=\"_blank\">MHRCQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1212692-magnum-hunter-eyes-more-sales-but-shares-slump\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Magnum Hunter eyes more sales, but shares slump</a></h4><ul>     <li>Magnum Hunter (MHR <font color=\"red\">-3.1%</font>) says sales of non-core assets are <a href=\"http://www.upstreamonline.com/live/article1334222.ece\" target=\"_blank\">set to be announced</a> in the near future, but shares are lower after <a href=\"https://seekingalpha.com/currents/post/1211042\" target=\"_blank\">Q2 earnings</a> and revenues miss expectations (<a href=\"https://seekingalpha.com/article/1622372-magnum-hunter-resources-corp-management-discusses-q3-2013-results-webcast\" target=\"_blank\">conference call</a>).</li>     <li>A big jump in expenses sent MHR to a $37.7M Q2 operating loss, but gains on disposals allowed it post a $165.4M net profit vs. a $14.5M loss a year ago.</li>     <li>Production rose 23% Y/Y on increased drilling of shale plays but was adversely impacted by shut-ins in the Appalachian division due to pipeline and liquid handling issues relating to MHR's midstream gathering facilities.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1212692\" data-linked=\"Magnum Hunter eyes more sales, but shares slump\" data-tweet=\"$MHRCQ - Magnum Hunter eyes more sales, but shares slump https://seekingalpha.com/news/1212692-magnum-hunter-eyes-more-sales-but-shares-slump?source=tweet\" data-url=\"https://seekingalpha.com/news/1212692-magnum-hunter-eyes-more-sales-but-shares-slump\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:52 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1212682\" data-ts=\"1376066777\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1212682-midday-top-10-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday top 10 gainers / Losers</a></h4><ul>     <li>\n<b>Midday top 10 gainers:</b> <a href=\"https://seekingalpha.com/symbol/PTIX\" title=\"Protagenic Therapeutics, Inc.\">PTIX</a> <font color=\"green\">+101%</font>. <a href=\"https://seekingalpha.com/symbol/BOSC\" title=\"B.O.S. Better Online Solutions\">BOSC</a> <font color=\"green\">+46%</font>. <a href=\"https://seekingalpha.com/symbol/GBR\" title=\"New Concept Energy, Inc.\">GBR</a> <font color=\"green\">+29%</font>. <a href=\"https://seekingalpha.com/symbol/UBNT\" title=\"Ubiquiti Networks, Inc.\">UBNT</a> <font color=\"green\">+27%</font>. <a href=\"https://seekingalpha.com/symbol/NOAH\" title=\"Noah Holdings Limited\">NOAH</a> <font color=\"green\">+26%</font>. <a href=\"https://seekingalpha.com/symbol/NPSP\" title=\"NPS Pharmaceuticals, Inc.\">NPSP</a> <font color=\"green\">+24%</font>. <a href=\"https://seekingalpha.com/symbol/GERN\" title=\"Geron Corporation\">GERN</a> <font color=\"green\">+22%</font>. <a href=\"https://seekingalpha.com/symbol/IFNY\" title=\"Infinity Energy Resources, Inc.\">OTCPK:IFNY</a> <font color=\"green\">+22%</font>. <a href=\"https://seekingalpha.com/symbol/AMED\" title=\"AMEDISYS Inc\">AMED</a> <font color=\"green\">+19%</font>. <a href=\"https://seekingalpha.com/symbol/RITT\" title=\"RiT Technologies Ltd.\">OTC:RITT</a> <font color=\"green\">+19%</font>.</li>\n<li>\n<b> Losers:</b> <a href=\"https://seekingalpha.com/symbol/MRGE-OLD\" title=\"Merge Healthcare Incorporated.\">MRGE</a> <font color=\"red\">-44%</font>. <a href=\"https://seekingalpha.com/symbol/CNYD\" title=\"China Yida Holding, Co.\">CNYD</a> <font color=\"red\">-27%</font>. <a href=\"https://seekingalpha.com/symbol/DNDN\" title=\"Dendreon Corporation\">DNDN</a> <font color=\"red\">-24%</font>. <a href=\"https://seekingalpha.com/symbol/YRCW\" title=\"YRC Worldwide, Inc.\">YRCW</a> <font color=\"red\">-17%</font>. <a href=\"https://seekingalpha.com/symbol/CRMB\" title=\"Crumbs Bake Shop, Inc\">CRMB</a> <font color=\"red\">-16%</font>. <a href=\"https://seekingalpha.com/symbol/EDS\" title=\"EXCEED COMPANY LTD.\">EDS</a> <font color=\"red\">-15%</font>. SLTC <font color=\"red\">-15%</font>. <a href=\"https://seekingalpha.com/symbol/BIOL\" title=\"Biolase, Inc.\">BIOL</a> <font color=\"red\">-15%</font>. <a href=\"https://seekingalpha.com/symbol/NPTN\" title=\"NeoPhotonics Corporation\">NPTN</a> <font color=\"red\">-14%</font>. <a href=\"https://seekingalpha.com/symbol/CPST\" title=\"Capstone Turbine Corporation\">CPST</a> <font color=\"red\">-13%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1212682\" data-linked=\"Midday top 10 gainers / Losers\" data-tweet=\"$RBBN $BOSC $GBR - Midday top 10 gainers / Losers https://seekingalpha.com/news/1212682-midday-top-10-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/1212682-midday-top-10-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:46 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1212522\" data-ts=\"1376066588\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NPTN\" target=\"_blank\">NPTN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1212522-neophotonics-slumps-on-lowered-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NeoPhotonics slumps on lowered guidance</a></h4><ul>\n<li>NeoPhotonics (<a href=\"https://seekingalpha.com/symbol/NPTN\" title=\"NeoPhotonics Corporation\">NPTN</a> <font color=\"red\">-13.6%</font>) shares are slumping after the company provided underwhelming Q3 guidance to go with its <a href=\"https://seekingalpha.com/currents/post/1211652\" target=\"_blank\">Q2 beat</a>.</li>\n<li>Revenue guidance of $72M-78M is below a consensus of $83.7M. EPS guidance of -$0.14 to -$0.04 is below a consensus of $0.05. (<a href=\"http://www.sec.gov/Archives/edgar/data/1227025/000119312513326870/d580406dex991.htm\" target=\"_blank\">8-K</a>).</li>\n<li>The numbers come shortly after telecom optical component rival Finisar <a href=\"https://seekingalpha.com/currents/post/1199532\" target=\"_blank\">raised</a> its July quarter guidance, and saw its shares take off in response. However, Finisar's guidance hike had more to do with datacom, rather than telecom, component sales.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1212522\" data-linked=\"NeoPhotonics slumps on lowered guidance\" data-tweet=\"$NPTN - NeoPhotonics slumps on lowered guidance https://seekingalpha.com/news/1212522-neophotonics-slumps-on-lowered-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/1212522-neophotonics-slumps-on-lowered-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:43 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1212652\" data-ts=\"1376065969\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VALE\" target=\"_blank\">VALE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1212652-vale-extends-gains-reaps-praise-for-cost-cutting-focus\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vale extends gains, reaps praise for cost-cutting focus</a></h4><ul>     <li>Vale (<a href=\"https://seekingalpha.com/symbol/VALE\" title=\"Vale S.A.\">VALE</a> <font color=\"green\">+5%</font>) shares extend strong gains following the Brazilian miner's <a href=\"https://seekingalpha.com/currents/post/1205272\" target=\"_blank\">Q2 results</a>, which look <a href=\"https://seekingalpha.com/currents/post/1208752\" target=\"_blank\">surprisingly strong</a> once a $2.8B currency hit is removed, and positive comments about China\u2019s demand for iron ore.</li>     <li>Nomura says Vale\u2019s strategy of focusing on the development of core projects while lowering its cost structure is <a href=\"http://blogs.barrons.com/emergingmarketsdaily/2013/08/09/vale-keeps-climbing-as-nomura-sees-miner-earning-significant-cash\" target=\"_blank\">starting to show favorable results</a>, which should allow the leverage of production growth finally set to come online starting in H2.</li>\n<li>The firm sees Vale earning \"significant\" cash, estimating 2014 and 2015 free cash flow yields at 3% and 4% respectively.</li>      </ul><div class=\"tiny-share-widget\" data-id=\"1212652\" data-linked=\"Vale extends gains, reaps praise for cost-cutting focus\" data-tweet=\"$VALE - Vale extends gains, reaps praise for cost-cutting focus https://seekingalpha.com/news/1212652-vale-extends-gains-reaps-praise-for-cost-cutting-focus?source=tweet\" data-url=\"https://seekingalpha.com/news/1212652-vale-extends-gains-reaps-praise-for-cost-cutting-focus\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1212632\" data-ts=\"1376065133\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DE\" target=\"_blank\">DE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1212632-deere-hit-by-a-couple-more-downgrades-on-weak-macro-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deere hit by a couple more downgrades on weak macro-outlook</a></h4><ul>\n<li>Deere (<a href=\"https://seekingalpha.com/symbol/DE\" title=\"Deere &amp; Company\">DE</a> <font color=\"red\">-1.8%</font>) slips on a couple of downgrades today, one from <a href=\"http://www.streetinsider.com/Downgrades/ISI+Group+Downgrades+Deere+%28DE%29+to+Neutral/8585686.html\" target=\"_blank\">ISI to Neutral</a> and another from <a href=\"http://www.streetinsider.com/Downgrades/UBS+Cuts+Deere+%28DE%29+to+Sell+as+Ag+Demand+Weakens/8586255.html\" target=\"_blank\">UBS to Sell</a>.</li>\n<li>UBS says it expects stock performance to mirror weakness in corn prices, which will pressure demand for agricultural equipment in the coming year.</li>\n<li>FY14 earnings are likely to decline, as farmers react to lower cash receipts and farm income.</li>\n<li>The moves follow a <a href=\"https://seekingalpha.com/market_currents/post/1198292\" target=\"_blank\">similiar downgrade</a> earlier this week from William Blair, who said farm-equipment markets will be challenged over the next couple of years as assets including corn, farmland and used equipment fall in value.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1212632\" data-linked=\"Deere hit by a couple more downgrades on weak macro-outlook\" data-tweet=\"$DE - Deere hit by a couple more downgrades on weak macro-outlook https://seekingalpha.com/news/1212632-deere-hit-by-a-couple-more-downgrades-on-weak-macro-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/1212632-deere-hit-by-a-couple-more-downgrades-on-weak-macro-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:18 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1212622\" data-ts=\"1376065037\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ROAN\" target=\"_blank\">ROAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1212622-goldman-sees-buy-the-dip-opportunity-in-linn-energy-linnco\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goldman sees buy-the-dip opportunity in Linn Energy, LinnCo</a></h4><ul>     <li>Goldman Sachs sees the two-day 10% drop in Linn Energy (LINE <font color=\"red\">-5.3%</font>) following <a href=\"https://seekingalpha.com/currents/post/1208582\" target=\"_blank\">Q2 results</a> as a <a href=\"http://www.streetinsider.com/Analyst+Comments/LINN+Energy+%28Line%29+Dip+Buying+Opp%2C+Says+Analyst/8586609.html\" target=\"_blank\">buy-the-dip opportunity</a>, maintaining Buy recommendations on LINE and LinnCo (LNCO <font color=\"red\">-6.7%</font>) with respective $34 and $35 price targets.</li>     <li>Goldman believes LINE was prudent in pulling back on plans for a distribution increase given uncertainties around the Berry Petroleum (<a href=\"https://seekingalpha.com/symbol/BRY\" title=\"Berry Petroleum Corp.\">BRY</a> <font color=\"red\">-1.2%</font>) acquisition and coverage currently running below 1x.</li>     <li>The firm reiterates concerns over LINE's hedge accounting and maintenance capital are overblown.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1212622\" data-linked=\"Goldman sees buy-the-dip opportunity in Linn Energy, LinnCo\" data-tweet=\"$ROAN $ROAN $LNCOQ - Goldman sees buy-the-dip opportunity in Linn Energy, LinnCo https://seekingalpha.com/news/1212622-goldman-sees-buy-the-dip-opportunity-in-linn-energy-linnco?source=tweet\" data-url=\"https://seekingalpha.com/news/1212622-goldman-sees-buy-the-dip-opportunity-in-linn-energy-linnco\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1212612\" data-ts=\"1376064551\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BKNG\" target=\"_blank\">BKNG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1212612-1000-plus-pts-assigned-to-priceline-following-q2-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">$1,000+ PTs assigned to Priceline following Q2 beat</a></h4><ul>\n<li>Analysts are rushing to give Priceline (PCLN <font color=\"green\">+4.6%</font>) $1,000+ PTs in the wake of the online travel giant's <a href=\"https://seekingalpha.com/currents/post/1209492\" target=\"_blank\">Q2 beat</a> and <a href=\"https://seekingalpha.com/currents/post/1209802\" target=\"_blank\">healthy guidance</a>.</li>\n<li>\n<a href=\"http://www.streetinsider.com/Analyst+Comments/Priceline+%28PCLN%29+Target+Raised+at+Cantor+Fitzgerald/8585881.html\" target=\"_blank\">Cantor</a> ($1,050) thinks Priceline not only <a href=\"https://seekingalpha.com/currents/post/1210472\" target=\"_blank\">performed well internationally</a>, but \"also likely gained ground in the US, benefiting from increased TV ads and Expedia's <a href=\"https://seekingalpha.com/currents/post/1197772\" target=\"_blank\">mis-execution</a> on TripAdvisor.\" It sees Priceline's \"best-in-class hotel inventory\" and Kayak's international expansion fueling additional share gains.</li>\n<li>\n<a href=\"http://www.streetinsider.com/Analyst+Comments/Priceline+%28PCLN%29+Price+Target+Raised+to+%241120+at+Deutsche+Bank/8585854.html\" target=\"_blank\">Deutsche</a> ($1,120) thinks Priceline's EBITDA margin (pressured lately by heavy ad spend) could be roughly flat Y/Y in Q3, a notable improvement from recent quarters.</li>\n<li>\n<a href=\"http://www.streetinsider.com/Analyst+Comments/priceline.com+%28PCLN%29+PT+Lifted+to+%241%2C100+at+Evercore/8585593.html\" target=\"_blank\">Evercore</a> ($1,100) declares Booking.com \"still enjoys the highest marketing efficiency in the industry.\" Its PT is based on a lofty multiple of 24x 2014E adjusted EPS.</li>\n<li>Priceline<a href=\"https://seekingalpha.com/article/1621192-priceline-coms-ceo-discusses-q2-2013-results-earnings-call-transcript\" target=\"_blank\"> noted on its CC</a> Booking.com now lists 330K+ hotels/accomodations, +40% Y/Y. The company attributed its 410 bps Y/Y op. margin drop to lower (online) ad ROIs, mix shifts, and growing offline ad spend for Kayak and Booking.com.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1212612\" data-linked=\"$1,000+ PTs assigned to Priceline following Q2 beat\" data-tweet=\"$BKNG - $1,000+ PTs assigned to Priceline following Q2 beat https://seekingalpha.com/news/1212612-1000-plus-pts-assigned-to-priceline-following-q2-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/1212612-1000-plus-pts-assigned-to-priceline-following-q2-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1212602\" data-ts=\"1376064330\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SQNM\" target=\"_blank\">SQNM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1212602-sequenom-spikes-higher\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sequenom spikes higher</a></h4><ul><li>Sequenom (<a href=\"https://seekingalpha.com/symbol/SQNM\" title=\"Sequenom, Inc.\">SQNM</a> <font color=\"green\">+5%</font>) pops on chatter that the company will be allowed to <a href=\"http://www.briefing.com/GeneralContent/InPlayEQ/Active/TickerSearch/TickerSearchInPlayEq.aspx?SearchTextBox=SQNM\" target=\"_blank\">pursue a ban</a> of a certain pre-natal test.</li></ul><div class=\"tiny-share-widget\" data-id=\"1212602\" data-linked=\"Sequenom spikes higher\" data-tweet=\"$SQNM - Sequenom spikes higher https://seekingalpha.com/news/1212602-sequenom-spikes-higher?source=tweet\" data-url=\"https://seekingalpha.com/news/1212602-sequenom-spikes-higher\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1212572\" data-ts=\"1376063788\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RIG\" target=\"_blank\">RIG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1212572-transocean-cut-to-neutral-at-global-hunter-shares-slip\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Transocean cut to Neutral at Global Hunter, shares slip</a></h4><ul>     <li>Transocean (<a href=\"https://seekingalpha.com/symbol/RIG\" title=\"Transocean Ltd.\">RIG</a> <font color=\"red\">-1.9%</font>) is <a href=\"http://www.streetinsider.com/Downgrades/Global+Hunter+Securities+Downgrades+Transocean+%28RIG%29+to+Neutral/8585616.html\" target=\"_blank\">downgraded</a> to Neutral from Buy with a $51 price target, down from $64, at Global Hunter, which notes a subdued outlook for both deepwater and midwater rigs.</li>\n<li>The firm says it nailed its forecast for revenue and operating expense, but its expectation for RIG to lower cost guidance through year-end and discuss potential further savings in 2014 did not occur.</li>\n<li>In addition to the subdued rig outlook, RIG indicated that <a href=\"https://seekingalpha.com/currents/post/1208792\" target=\"_blank\">idle time</a> in the future is likely, which generally leads to an erosion in rates.</li>     <li>Initial reaction to RIG's largely <a href=\"https://seekingalpha.com/currents/post/1204772\" target=\"_blank\">in-line Q2</a> had been more moderate, as Jefferies and Stephens reiterated <a href=\"http://blogs.barrons.com/stockstowatchtoday/2013/08/08/transocean-falls-after-in-line-q2/\" target=\"_blank\">Hold/Neutral ratings</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1212572\" data-linked=\"Transocean cut to Neutral at Global Hunter, shares slip\" data-tweet=\"$RIG - Transocean cut to Neutral at Global Hunter, shares slip https://seekingalpha.com/news/1212572-transocean-cut-to-neutral-at-global-hunter-shares-slip?source=tweet\" data-url=\"https://seekingalpha.com/news/1212572-transocean-cut-to-neutral-at-global-hunter-shares-slip\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1212582\" data-ts=\"1376063758\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMED\" target=\"_blank\">AMED</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1212582-amedisys-soars-on-kkr-stake\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amedisys soars on KKR stake</a></h4><ul><li>Shares of Amedisys (<a href='https://seekingalpha.com/symbol/AMED' title='AMEDISYS Inc'>AMED</a> <font color='green'>+21.8%</font>) are up sharply on the session as KKR reveals a new 8.5% stake in the company. (<a href=\"http://www.sec.gov/Archives/edgar/data/896262/000110465913061771/a13-18260_1sc13d.htm\" target=\"_blank\">13D</a>)</li><li>CRT takes the <a href=\"http://www.streetinsider.com/Upgrades/CRT+Capital+Upgrades+Amedisys+%28AMED%29+to+Fairly+Valued/8585649.html\" target=\"_blank\">shares to Fairly Valued</a> from Sell. (<a href=\"http://blogs.barrons.com/stockstowatchtoday/2013/08/09/amedisys-jumps-22-on-kkr-stake/\" target=\"_blank\">details</a>)</li></ul><div class=\"tiny-share-widget\" data-id=\"1212582\" data-linked=\"Amedisys soars on KKR stake\" data-tweet=\"$AMED - Amedisys soars on KKR stake https://seekingalpha.com/news/1212582-amedisys-soars-on-kkr-stake?source=tweet\" data-url=\"https://seekingalpha.com/news/1212582-amedisys-soars-on-kkr-stake\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:55 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1212562\" data-ts=\"1376062636\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EBIX\" target=\"_blank\">EBIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1212562-ebix-slumps-following-mixed-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ebix slumps following mixed Q2 results</a></h4><ul>\n<li>Embattled Ebix (<a href=\"https://seekingalpha.com/symbol/EBIX\" title=\"Ebix Inc\">EBIX</a> <font color=\"red\">-8%</font>) is selling off after slightly beating Q2 EPS estimates, and missing revenue estimates by $1M.</li>\n<li>Ebix posted 7% Y/Y sales growth in Q2, a slowdown from Q1's 20%.</li>\n<li>Op. margin was 37.8%, +110 bps Q/Q and +110 bps Y/Y, in spite of rising legal costs.</li>\n<li>Only $2.5M was spent on buybacks. Ebix has $102.9M remaining under its buyback authorization. $5.6M was spent to pay down bank debt; net debt now stands at $30.8M.</li>\n<li>Ebix is being investigated the SEC and the Atlanta U.S. Attorney's office, and reportedly by the FBI. Shares crashed on Tuesday thanks to Bloomberg's <a href=\"https://seekingalpha.com/currents/post/1198112\" target=\"_blank\">FBI report</a>, but subsequently <a href=\"https://seekingalpha.com/currents/post/1199712\" target=\"_blank\">recouped</a> a majority of their losses.</li>\n<li>\n<a href=\"https://seekingalpha.com/currents/post/1211152\" target=\"_blank\">Q2 results</a>, PR</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1212562\" data-linked=\"Ebix slumps following mixed Q2 results\" data-tweet=\"$EBIX - Ebix slumps following mixed Q2 results https://seekingalpha.com/news/1212562-ebix-slumps-following-mixed-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/1212562-ebix-slumps-following-mixed-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:37 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1212542\" data-ts=\"1376062596\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CORT\" target=\"_blank\">CORT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1212542-corcept-therapeutics-slides-on-weak-q2-earnings-multiple-downgrades\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Corcept Therapeutics slides on weak Q2 earnings; multiple downgrades</a></h4><ul>\n<li>Corcept Therapeutics (<a href=\"https://seekingalpha.com/symbol/CORT\" title=\"Corcept Therapeutics Incorporated\">CORT</a> <font color=\"red\">-5.3%</font>) slips after posting a mixed Q2, reporting an EPS loss that came in better than estimates but missing on its top line revenue number.</li>\n<li>Continues to enroll patients in its Phase 3 study of of mifepristone, Korlym's active ingredient, for the treatment of psychotic depression. Results are expected to be released in Q314.</li>\n<li>Cash balance as of June 30 was $72.2M, as compared to $93M at December 31, 2012, reflecting approximately $20.8M spent on operations during H113.</li>\n<li>Janney Montgomery, Credit Suisse and Ladenbug Thalmann <a href=\"http://www.briefing.com/GeneralContent/InPlayEQ/Active/TickerSearch/TickerSearchInPlayEq.aspx?SearchTextBox=CORT\" target=\"_blank\">all downgraded</a> the shares to Neutral on the back of the results.</li>\n<li>Ladenburg cites a slow Korlym commercial launch and the lack of strong confidence about future commercial prospects as reasons for the downgrade.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1212542\" data-linked=\"Corcept Therapeutics slides on weak Q2 earnings; multiple downgrades\" data-tweet=\"$CORT - Corcept Therapeutics slides on weak Q2 earnings; multiple downgrades https://seekingalpha.com/news/1212542-corcept-therapeutics-slides-on-weak-q2-earnings-multiple-downgrades?source=tweet\" data-url=\"https://seekingalpha.com/news/1212542-corcept-therapeutics-slides-on-weak-q2-earnings-multiple-downgrades\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:36 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1212532\" data-ts=\"1376062551\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EVEP-OLD\" target=\"_blank\">EVEP-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1212532-ev-energy-shares-rise-after-q2-results-284m-utica-shale-sale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EV Energy shares rise after Q2 results, $284M Utica shale sale</a></h4><ul>     <li>Along with its <a href=\"https://seekingalpha.com/currents/post/1211102\" target=\"_blank\">Q2 results</a>, EV Energy (<a href=\"https://seekingalpha.com/symbol/EVEP-OLD\" title=\"EV Energy Partners, L.P.\">EVEP-OLD</a> <font color=\"green\">+2.6%</font>) announces a $284M deal with an undisclosed buyer to sell ~22.5K acres in Ohio\u2019s Utica shale play.</li>     <li>The deal is the first Utica disposal by EVEP, which suggests further sales are ahead.</li>     <li>Adjusted Q2 EBITDA was $52.6M, +9% Q/Q but -20% Y/Y; distributable cash flow of $26.1M +20% Q/Q but -24% Y/Y; production was 172.3M cfe/day, +4% Q/Q and +6% Y/Y.</li>     <li>EVEP also is bringing onstream its 200M cf/day Utica East Ohio midstream gas processing facility, which is processing 85M cf/day and set to increase as more wells are hooked up.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1212532\" data-linked=\"EV Energy shares rise after Q2 results, $284M Utica shale sale\" data-tweet=\"$EVEP-OLD - EV Energy shares rise after Q2 results, $284M Utica shale sale https://seekingalpha.com/news/1212532-ev-energy-shares-rise-after-q2-results-284m-utica-shale-sale?source=tweet\" data-url=\"https://seekingalpha.com/news/1212532-ev-energy-shares-rise-after-q2-results-284m-utica-shale-sale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:35 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1212482\" data-ts=\"1376061234\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RGSE\" target=\"_blank\">RGSE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1212482-real-goods-solar-acquires-mercury-solar-systems\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Real Goods Solar acquires Mercury Solar Systems</a></h4><ul>\n<li>Shares of Real Goods Solar (RSOL <font color=\"green\">+10.1%</font>) flare up after the company <a href=\"http://finance.yahoo.com/news/real-goods-solar-acquire-mercury-123100466.html\" target=\"_blank\">announces</a> it will acquire fellow solar installation services firm Mercury Solar Systems in exchange for 7.9M class A shares (current value of $18.1M).</li>\n<li>Mercury, founded in '08, has installed over 50MW worth of solar capacity over its lifetime, courtesy of 2K+ installations. The company currently has 50+ employees.</li>\n<li>RSOL appears to be getting a good bargain on the basis of P/S arbitrage. RSOL's TTM P/S ratio is 0.68. With 2012 revenue of $35M, $10M in cash, and no debt, Mercury's purchase price seems to be a deal, and its assets will provide RSOL with working capital for expansion.</li>\n<li>Real Goods Solar previously filed a shelf registration to offer up to $25M worth of class A shares in July. (<a href=\"http://www.sec.gov/Archives/edgar/data/1425565/000119312513295854/d570232ds3.htm\" target=\"_blank\">S-3</a>)</li>\n<li>\n<a href=\"https://seekingalpha.com/currents/post/1033221\" target=\"_blank\">Previous</a>: Real Good Solar skyrockets after SA contributor makes bull case</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1212482\" data-linked=\"Real Goods Solar acquires Mercury Solar Systems\" data-tweet=\"$RGSE - Real Goods Solar acquires Mercury Solar Systems https://seekingalpha.com/news/1212482-real-goods-solar-acquires-mercury-solar-systems?source=tweet\" data-url=\"https://seekingalpha.com/news/1212482-real-goods-solar-acquires-mercury-solar-systems\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1212502\" data-ts=\"1376061087\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BECN\" target=\"_blank\">BECN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1212502-beacon-roofing-sinks-as-conference-call-brings-reduced-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Beacon Roofing sinks as conference call brings reduced guidance</a></h4><ul>     <li>Beacon Roofing Supply (<a href=\"https://seekingalpha.com/symbol/BECN\" title=\"Beacon Roofing Supply, Inc.\">BECN</a> <font color=\"red\">-6.6%</font>) sinks during the <a href=\"https://seekingalpha.com/currents/post/1212162\" target=\"_blank\">FQ3 earnings</a> conference call as it guides FY 2013 EPS lower, to $1.50-$1.60 vs. $1.80 consensus estimate.</li>     <li>Briefing.com reports BECN said during the call: \"If demand picks up and solid price is realized, 5% plus or so for the quarter, we could achieve the higher end of that range, if not, it will be in the lower end of the range.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"1212502\" data-linked=\"Beacon Roofing sinks as conference call brings reduced guidance\" data-tweet=\"$BECN - Beacon Roofing sinks as conference call brings reduced guidance https://seekingalpha.com/news/1212502-beacon-roofing-sinks-as-conference-call-brings-reduced-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/1212502-beacon-roofing-sinks-as-conference-call-brings-reduced-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1212492\" data-ts=\"1376060822\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RDNT\" target=\"_blank\">RDNT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1212492-radnet-gains-on-a-solid-q2-earnings-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RadNet gains on a solid Q2 earnings beat</a></h4><ul>\n<li>RadNet (<a href=\"https://seekingalpha.com/symbol/RDNT\" title=\"RadNet, Inc.\">RDNT</a> <font color=\"green\">+1.9%</font>) gains after its <a href=\"https://seekingalpha.com/market_currents/post/1210922\" target=\"_blank\">Q2 easily topped estimates</a> this morning.</li>\n<li>Overall volume +7.8% Y/Y; MRI volume +10.7%, CT volume -0.6% and PET/CT volume -2.4%.</li>\n<li>Overall same-center volume -0.3% over the prior year's same quarter; MRI volume +0.3%, CT volume -6.3% and PET/CT volume -5.9%.</li>\n<li>For 2013, the company reaffirms its revenue guidance of $700M - $730M.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1212492\" data-linked=\"RadNet gains on a solid Q2 earnings beat\" data-tweet=\"$RDNT - RadNet gains on a solid Q2 earnings beat https://seekingalpha.com/news/1212492-radnet-gains-on-a-solid-q2-earnings-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/1212492-radnet-gains-on-a-solid-q2-earnings-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:07 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1212442\" data-ts=\"1376059957\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IRWD\" target=\"_blank\">IRWD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1212442-ims-script-data-update-for-key-biotech-drugs-week-ending-08-02\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IMS script data update for key biotech drugs, week ending 08/02</a></h4><ul><li>Ironwood (<a href='https://seekingalpha.com/symbol/IRWD' title='Ironwood Pharmaceuticals, Inc.'>IRWD</a> <font color='green'>+2.3%</font>) and Forest's (<a href='https://seekingalpha.com/symbol/FRX' title='Forest Laboratories, Inc.'>FRX</a> <font color='red'>-0.7%</font>) <a href=\"https://twitter.com/AndyBiotech/status/365842437559685123\" target=\"_blank\">Linzess</a>: TRx 12,969.</li><li>Ariad's (<a href='https://seekingalpha.com/symbol/ARIA' title='ARIAD Pharmaceuticals, Inc.'>ARIA</a> <font color='red'>-0.2%</font>) <a href=\"https://twitter.com/andybiotech/status/365839971048886272\" target=\"_blank\">Iclusig</a>: TRx 118.</li><li>Arena's (<a href='https://seekingalpha.com/symbol/ARNA' title='Arena Pharmaceuticals, Inc.'>ARNA</a> <font color='red'>-1.1%</font>) <a href=\"https://twitter.com/andybiotech/status/365838776158789632\" target=\"_blank\">Belviq</a>: TRx 3,168.</li><li>Vivus' (<a href='https://seekingalpha.com/symbol/VVUS' title='Vivus, Inc.'>VVUS</a> <font color='red'>-2.4%</font>) Qsymia: TRx 8,555.</li></ul><div class=\"tiny-share-widget\" data-id=\"1212442\" data-linked=\"IMS script data update for key biotech drugs, week ending 08/02\" data-tweet=\"$IRWD $IRWD $FRX - IMS script data update for key biotech drugs, week ending 08/02 https://seekingalpha.com/news/1212442-ims-script-data-update-for-key-biotech-drugs-week-ending-08-02?source=tweet\" data-url=\"https://seekingalpha.com/news/1212442-ims-script-data-update-for-key-biotech-drugs-week-ending-08-02\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1212432\" data-ts=\"1376059696\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MCPIQ\" target=\"_blank\">MCPIQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1212432-molycorp-minus-10-percent-after-q2-results-fundamentals-nearing-a-bottom\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Molycorp -10% after Q2 results, fundamentals &quot;nearing a bottom&quot;</a></h4><ul>     <li>Molycorp (MCP <font color=\"red\">-10.5%</font>) shares slide after <a href=\"https://seekingalpha.com/currents/post/1209922\" target=\"_blank\">disappointing Q2 results</a>, but Goldman Sachs believes <a href=\"http://www.streetinsider.com/Analyst+Comments/Molycorp+%28MCP%29+Fundamentals+Nearing+Bottom+But+Not+Time+to+Pull+Trigger/8586429.html\" target=\"_blank\">fundamentals are nearing a bottom</a> and maintains its Neutral rating and $6 price target.</li>     <li>The firm notes several positive developments during the quarter, including normalizing REO demand as customer inventory destocking appears to have subsided and H2 order patterns are on the mend.</li>     <li>Goldman says it's not time to pull the trigger, pending clarity around MCP's expected Sept. closing on a $125M revolver and commissioning of its chlor-alkali facility, a key factor in achieving targeted sub-$10/kg production costs and profitability.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1212432\" data-linked=\"Molycorp -10% after Q2 results, fundamentals &quot;nearing a bottom&quot;\" data-tweet=\"$MCPIQ - Molycorp -10% after Q2 results, fundamentals &quot;nearing a bottom&quot; https://seekingalpha.com/news/1212432-molycorp-minus-10-percent-after-q2-results-fundamentals-nearing-a-bottom?source=tweet\" data-url=\"https://seekingalpha.com/news/1212432-molycorp-minus-10-percent-after-q2-results-fundamentals-nearing-a-bottom\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:48 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1212422\" data-ts=\"1376059543\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SSNLF\" target=\"_blank\">SSNLF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1212422-samsung-confirms-novaled-deal-universal-display-still-up-sharply\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Samsung confirms Novaled deal; Universal Display still up sharply</a></h4><ul>\n<li>Samsung (<a href=\"https://seekingalpha.com/symbol/SSNLF\" title=\"Samsung Electronics Co., Ltd.\">OTC:SSNLF</a>) and affiliate Cheil Industries (a maker of OLED materials) are <a href=\"http://online.wsj.com/article/SB10001424127887323977304579002112333714996.html\" target=\"_blank\">buying</a> German OLED materials/tech provider Novaled for \u20ac260M ($347M).</li>\n<li>Cheil's CEO promises the deal will yield major OLED R&amp;D synergies. Samsung says it's paying ~10x revenue.</li>\n<li>Universal Display (<a href=\"https://seekingalpha.com/symbol/OLED\" title=\"Universal Display Corporation\">OLED</a> <font color=\"green\">+13.4%</font>) shares, which <a href=\"https://seekingalpha.com/currents/post/1171012\" target=\"_blank\">dove last week</a> on a Samsung/Novaled report, and partly rebounded after <a href=\"https://seekingalpha.com/currents/post/1171152\" target=\"_blank\">analysts argued </a>Novaled's offerings are complementary, is below yesterday's AH highs, but remain sharply higher in response to its <a href=\"https://seekingalpha.com/currents/post/1209832\" target=\"_blank\">Q2 beat</a> and strong <a href=\"https://seekingalpha.com/currents/post/1209982\" target=\"_blank\">full-year guidance</a>.</li>\n<li>Universal mentioned on its <a href=\"https://seekingalpha.com/article/1622052-universal-displays-ceo-discusses-q2-2013-results-earnings-call-transcript\" target=\"_blank\">Q2 CC</a> sales of green host materials (used in newer Samsung phones, including the Galaxy S4) rose 192% Q/Q and over 6x Y/Y to $9M. Likewise, green emitter sales rose 186% Q/Q and over 8x Y/Y to $13.1M. Red emitter sales totaled $3.6M, +25% Q/Q but -29% Y/Y.</li>\n<li>The company added product mix and price cuts impacted its materials gross margin, and that there could be some additional margin pressure if host materials sales \"proportionally grow faster\" than emitter sales.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1212422\" data-linked=\"Samsung confirms Novaled deal; Universal Display still up sharply\" data-tweet=\"$SSNLF $SSNLF $OLED - Samsung confirms Novaled deal; Universal Display still up sharply https://seekingalpha.com/news/1212422-samsung-confirms-novaled-deal-universal-display-still-up-sharply?source=tweet\" data-url=\"https://seekingalpha.com/news/1212422-samsung-confirms-novaled-deal-universal-display-still-up-sharply\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:45 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1212412\" data-ts=\"1376059365\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WMGI\" target=\"_blank\">WMGI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1212412-wright-medical-slides-after-fda-issues-not-approvable-letter-for-its-augment-bone-graft\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wright Medical slides after FDA issues not-approvable letter for its Augment Bone Graft</a></h4><ul>\n<li>Wright Medical Group (<a href=\"https://seekingalpha.com/symbol/WMGI\" title=\"Wright Medical Group, Inc.\">WMGI</a> <font color=\"red\">-8.3%</font>) takes a hit today after the FDA issues a \"not-approvable letter\" for its Augment Bone Graft, noting problems with the clinical study.</li>\n<li>The device, which is designed as an alternative to autograft in orthopedic surgeries, involves the use of tissue from another part of a patient's body.</li>\n<li>The agency said that the study enrolled people who were predominantly low risk, and may not have needed the procedures.</li>\n<li>Additionally, it was unsure whether a similar result might have been achieved without any graft material.</li>\n<li>It concluded that it may be necessary to perform a new clinical study, with a well-defined high-risk population.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1212412\" data-linked=\"Wright Medical slides after FDA issues not-approvable letter for its Augment Bone Graft\" data-tweet=\"$WMGI - Wright Medical slides after FDA issues not-approvable letter for its Augment Bone Graft https://seekingalpha.com/news/1212412-wright-medical-slides-after-fda-issues-not-approvable-letter-for-its-augment-bone-graft?source=tweet\" data-url=\"https://seekingalpha.com/news/1212412-wright-medical-slides-after-fda-issues-not-approvable-letter-for-its-augment-bone-graft\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:42 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1212362\" data-ts=\"1376058404\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JCP\" target=\"_blank\">JCP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1212362-boardroom-brawl-at-j-c-penney-sends-shares-lower\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Boardroom brawl at J.C. Penney sends shares lower</a></h4><ul><li>Shares of J.C. Penney (<a href='https://seekingalpha.com/symbol/JCP' title='J.C. Penney Company Inc.'>JCP</a> <font color='red'>-3.7%</font>)&nbsp;have given back around half of yesterday's gains as it looks like Bill Ackman's <a href=\"https://seekingalpha.com/currents/post/1208692\" target=\"_blank\">letter to the board</a> may have created a situation that is more contentious than he bargained for.<br></li><li>\"It's turned into a full-fledged boardroom brawl,\" CNBC's Scott Wapner says, referencing JCP's rather <a href=\"https://seekingalpha.com/currents/post/1210642\" target=\"_blank\">contemptuous response</a> to the letter.</li><li>Yale's Jeff Sonnenfeld calls the Pershing Square chief \"an <a href=\"http://www.cnbc.com/id/100952143\" target=\"_blank\">angry guy</a> going through his temper tantrums,\" before suggesting that it was indeed Ackman's actions (i.e. bringing in Ron Johnson)&nbsp;that tanked the stock in the first place.</li><li>The only thing to say here is that investors dislike uncertainty and the situation seems to have gotten a bit more uncertain for JCP after yesterday.</li></ul><div class=\"tiny-share-widget\" data-id=\"1212362\" data-linked=\"Boardroom brawl at J.C. Penney sends shares lower\" data-tweet=\"$JCP - Boardroom brawl at J.C. Penney sends shares lower https://seekingalpha.com/news/1212362-boardroom-brawl-at-j-c-penney-sends-shares-lower?source=tweet\" data-url=\"https://seekingalpha.com/news/1212362-boardroom-brawl-at-j-c-penney-sends-shares-lower\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1212352\" data-ts=\"1376058205\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RIO\" target=\"_blank\">RIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1212352-mongolia-considering-ipo-of-its-stake-in-rio-tinto-mine\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mongolia considering IPO of its stake in Rio Tinto mine</a></h4><ul>     <li>The government of Mongolia is studying <a href=\"http://www.bloomberg.com/news/2013-08-09/mongolia-studying-ipo-of-stake-in-6-6-billion-rio-mine.html\" target=\"_blank\">converting its 34% stake</a> in the <a href=\"https://seekingalpha.com/currents/search?query=oyu+tolgoi\" target=\"_blank\">Oyu Tolgoi</a> copper and gold mine into a public company.</li>     <li>By giving a stake to Mongolian citizens who have complained that the project only benefits foreign investors, the government likely would find it easier to negotiate with partner Rio Tinto (<a href=\"https://seekingalpha.com/symbol/RIO\" title=\"Rio Tinto plc\">RIO</a> <font color=\"green\">+3.4%</font>).</li>     <li>Rio, which controls 66% of the mine through its majority stake in Turquoise Hill Resources (<a href=\"https://seekingalpha.com/symbol/TRQ\" title=\"Turquoise Hill Resources Ltd.\">TRQ</a> <font color=\"green\">+0.2%</font>), started shipments from the mine last month following delays as Mongolia sought to ensure revenue passed through domestic banks.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1212352\" data-linked=\"Mongolia considering IPO of its stake in Rio Tinto mine\" data-tweet=\"$RIO $RIO $TRQ - Mongolia considering IPO of its stake in Rio Tinto mine https://seekingalpha.com/news/1212352-mongolia-considering-ipo-of-its-stake-in-rio-tinto-mine?source=tweet\" data-url=\"https://seekingalpha.com/news/1212352-mongolia-considering-ipo-of-its-stake-in-rio-tinto-mine\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1212332\" data-ts=\"1376057531\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CVT\" target=\"_blank\">CVT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1212332-cvent-skyrockets-following-ipo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cvent skyrockets following IPO</a></h4><ul>     <li>Cvent (NYSE:<a href=\"https://seekingalpha.com/symbol/CVT\" title=\"Cvent, Inc.\">CVT</a>) shares opened at $38 and are currently at $37.26, <strong><font color=\"green\">up 77.4%</font></strong> from an IPO price of $21.</li>     <li>That gives the company a valuation of $1.44B, or a lofty 17x 2012 sales.</li>     <li>For reference, larger/slower-growing rival Active Network only has a market cap of $614M, and trades at a mere 1.5x 2012 sales.</li>     <li>\n<a href=\"https://seekingalpha.com/currents/post/1212072\" target=\"_blank\">IPO pricing/competition</a>, <a href=\"http://www.sec.gov/Archives/edgar/data/1122897/000119312513324069/d578905ds1a.htm\" target=\"_blank\">S-1</a>, <a href=\"https://seekingalpha.com/currents/post/1124952\" target=\"_blank\">2012/Q1 results</a>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"1212332\" data-linked=\"Cvent skyrockets following IPO\" data-tweet=\"$CVT - Cvent skyrockets following IPO https://seekingalpha.com/news/1212332-cvent-skyrockets-following-ipo?source=tweet\" data-url=\"https://seekingalpha.com/news/1212332-cvent-skyrockets-following-ipo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1212302\" data-ts=\"1376057030\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INFO\" target=\"_blank\">INFO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1212302-deutsche-upgrades-ihs\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deutsche upgrades IHS</a></h4><ul>     <li>Shares of IHS <font color=\"green\">+4%</font> \"have not worked YTD or over one year,\" Deutsche's Paul Ginocchio says flatly, but \"the improving economy will lead to accelerating revenue growth, just as  the uncertain global economy hurt revenue over the last year,\" he adds.</li>     <li>Shares are <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/13/08/3827416/update-deutsche-bank-upgrades-ihs-on-positive-outlook\" target=\"_blank\">upgraded</a> to Buy from Hold.</li>     <li>Price target raised to $125 from $105.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1212302\" data-linked=\"Deutsche upgrades IHS\" data-tweet=\"$INFO - Deutsche upgrades IHS https://seekingalpha.com/news/1212302-deutsche-upgrades-ihs?source=tweet\" data-url=\"https://seekingalpha.com/news/1212302-deutsche-upgrades-ihs\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:03 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1212202\" data-ts=\"1376056706\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRGE\" target=\"_blank\">MRGE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1212202-merge-healthcare-collapsing-on-q2-miss-ceo-resignation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Merge Healthcare collapsing on Q2 miss, CEO resignation</a></h4><ul>\n<li>Merge Healthcare (<a href=\"https://seekingalpha.com/symbol/MRGE-OLD\" title=\"Merge Healthcare Incorporated.\">MRGE</a> <font color=\"red\">-41.8%</font>) is in free-fall, after releasing disappointing <a href=\"https://seekingalpha.com/currents/post/1211192\" target=\"_blank\">Q2 results</a>.</li>\n<li>The company attributes its results to \"continued reluctance amongst large health systems to move forward with enterprise purchases.\"</li>\n<li>Merge also announces the resignation of CEO Jeffery Surges; he will be replaced by Justin Dearborn, who has previously served as Merge's CEO and CFO, and most recently as President and CEO of Merge's DNA unit. (<a href=\"http://www.sec.gov/Archives/edgar/data/944765/000114036113031304/ex99_1.htm\" target=\"_blank\">8K</a>)</li>\n<li>Merge is also appointing operations EVP Nancy Koenig to the newly-created position of COO, and giving her Surges' vacated board seat.</li>\n<li>A silver lining: backlog in the clinical trials unit, for which revenue is 100% subscription-based, grew 28.7% Y/Y to $45.7M.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1212202\" data-linked=\"Merge Healthcare collapsing on Q2 miss, CEO resignation\" data-tweet=\"$MRGE $MRGE-OLD - Merge Healthcare collapsing on Q2 miss, CEO resignation https://seekingalpha.com/news/1212202-merge-healthcare-collapsing-on-q2-miss-ceo-resignation?source=tweet\" data-url=\"https://seekingalpha.com/news/1212202-merge-healthcare-collapsing-on-q2-miss-ceo-resignation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1212232\" data-ts=\"1376056141\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CUR\" target=\"_blank\">CUR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1212232-neuralstem-gives-clinical-update-with-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Neuralstem gives clinical update with Q2 results</a></h4><ul>\n<li>Neuralstem (<a href=\"https://seekingalpha.com/symbol/CUR\" title=\"Neuralstem, Inc.\">CUR</a> <font color=\"red\">-1.3%</font>) posts a Q2 loss of $0.09 per share, missing estimates by $0.04. The company also provided a clinical update \u2014 highlights are below.</li>\n<li>NSI-566 ALS Phase II trial to begin this month or next.</li>\n<li>Institutional Review Board approval for NSI-566 chronic spinal cord injury trial expected by the end of the summer.</li>\n<li>Dosing of patients in the SI-566 ischemic stroke Phase I/II trial, in Beijing should begin this month or next. <br>\n</li>\n<li>Data from NSI-189 MDD trial should come in H2. (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1212232\" data-linked=\"Neuralstem gives clinical update with Q2 results\" data-tweet=\"$CUR $SNCA - Neuralstem gives clinical update with Q2 results https://seekingalpha.com/news/1212232-neuralstem-gives-clinical-update-with-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/1212232-neuralstem-gives-clinical-update-with-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:49 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1212222\" data-ts=\"1376055878\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTR\" target=\"_blank\">NTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1212222-potash-mosaic-intrepid-potash-open-higher-after-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Potash, Mosaic, Intrepid Potash open higher after upgrade</a></h4><ul>     <li>Potash (POT <font color=\"green\">+1.5%</font>), Mosaic (<a href=\"https://seekingalpha.com/symbol/MOS\" title=\"The Mosaic Company\">MOS</a> <font color=\"green\">+2.4%</font>) and Intrepid Potash (<a href=\"https://seekingalpha.com/symbol/IPI\" title=\"Intrepid Potash, Inc.\">IPI</a> <font color=\"green\">+1.4%</font>) shares move higher at the open following <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/13/08/3827456/potash-mosaic-intrepid-potash-shares-move-higher-followi\" target=\"_blank\">upgrades</a> by BGC Partners, which says there is  \"too much at stake\" for the two parties involved in the <a href=\"https://seekingalpha.com/currents/search?query=potash+cartel\" target=\"_blank\">Belarusian Potash venture</a> to remain independent for a while longer.</li>     <li>The firm raises each stock from Hold to Buy, setting a $37 price target on POT, a $50 target on MOS and a price target of $16 on IPI.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1212222\" data-linked=\"Potash, Mosaic, Intrepid Potash open higher after upgrade\" data-tweet=\"$NTR $NTR $MOS - Potash, Mosaic, Intrepid Potash open higher after upgrade https://seekingalpha.com/news/1212222-potash-mosaic-intrepid-potash-open-higher-after-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/1212222-potash-mosaic-intrepid-potash-open-higher-after-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1212192\" data-ts=\"1376055662\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CSCO\" target=\"_blank\">CSCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1212192-a-roundup-of-tech-analyst-ratings-changes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">A roundup of tech analyst ratings changes</a></h4><ul><li>Cisco (<a href='https://seekingalpha.com/symbol/CSCO' title='Cisco Systems, Inc.'>CSCO</a> - unchanged) has been upgraded to Neutral by JPMorgan ahead of its Aug. 14 FQ4 report.</li><li>Baidu (<a href='https://seekingalpha.com/symbol/BIDU' title='Baidu, Inc.'>BIDU</a> <font color='green'>+2.5%</font>) has been upgraded to Buy by Citi following a <a href=\"https://www.google.com/finance?chdnp=1&amp;chdd=1&amp;chds=1&amp;chdv=1&amp;chvs=maximized&amp;chdeh=0&amp;chfdeh=0&amp;chdet=1376069400000&amp;chddm=11252&amp;chls=IntervalBasedLine&amp;q=NASDAQ:BIDU&amp;ntsp=1&amp;ei=Zu8EUqDxOMW5iwL2twE\" target=\"_blank\">50%+ run-up</a> since early July.</li><li>SunEdison (SUNE <font color='red'>-2.4%</font>) has been cut to Hold by Ardour Capital two days after posting a <a href=\"https://seekingalpha.com/currents/post/1200152\" target=\"_blank\">mixed Q2 report</a>.</li><li>Accenture (<a href='https://seekingalpha.com/symbol/ACN' title='Accenture plc'>ACN</a> <font color='green'>+0.7%</font>) has been upgraded to Outperform by Baird.</li><li>Orbitz (<a href='https://seekingalpha.com/symbol/OWW' title='Orbitz Worldwide, Inc.'>OWW</a> <font color='red'>-0.9%</font>) has been cut to Neutral by Lazard following yesterday's <a href=\"https://seekingalpha.com/currents/post/1210472\" target=\"_blank\">huge post-earnings gains</a>.</li><li>inContact (<a href='https://seekingalpha.com/symbol/SAAS' title='inContact, Inc.'>SAAS</a> <font color='red'>-8%</font>) has been cut to Hold by Benchmark following its <a href=\"https://seekingalpha.com/currents/post/1210222\" target=\"_blank\">Q2 revenue miss</a>.</li><li>Take-Two (<a href='https://seekingalpha.com/symbol/TTWO' title='Take-Two Interactive Software, Inc.'>TTWO</a> <font color='green'>+1.3%</font>) has been started at Buy by Benchmark.</li><li>Ixia (<a href='https://seekingalpha.com/symbol/XXIA' title='Ixia'>XXIA</a> <font color='green'>+1.9%</font>) has been started at Buy by Jefferies.</li></ul><div class=\"tiny-share-widget\" data-id=\"1212192\" data-linked=\"A roundup of tech analyst ratings changes\" data-tweet=\"$CSCO $CSCO $BIDU - A roundup of tech analyst ratings changes https://seekingalpha.com/news/1212192-a-roundup-of-tech-analyst-ratings-changes?source=tweet\" data-url=\"https://seekingalpha.com/news/1212192-a-roundup-of-tech-analyst-ratings-changes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1211982\" data-ts=\"1376054234\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1211982-premarket-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/UBNT' title='Ubiquiti Networks, Inc.'>UBNT</a> <font color='green'>+28%</font>. <a href='https://seekingalpha.com/symbol/GERN' title='Geron Corporation'>GERN</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/MEET' title='The Meet Group, Inc.'>MEET</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/OLED' title='Universal Display Corporation'>OLED</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/NIHD' title='NII Holdings, Inc.'>NIHD</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/YONG' title='Yongye International Inc'>YONG</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/NPSP' title='NPS Pharmaceuticals, Inc.'>NPSP</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/RAX' title='Rackspace Hosting, Inc.'>RAX</a> <font color='green'>+10%</font>. RSOL <font color='green'>+10%</font>. PCLN <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/IRE' title='The Governor and Company of the Bank of Ireland'>IRE</a> <font color='green'>+%</font>. BBRY <font color='green'>+6%</font>. <br><b>Losers:</b> <a href='https://seekingalpha.com/symbol/DNDN' title='Dendreon Corporation'>DNDN</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/CPST' title='Capstone Turbine Corporation'>CPST</a> <font color='red'>-16%</font>. MCP <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/TPLM' title='Triangle Petroleum Corporation'>TPLM</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/WMGI' title='Wright Medical Group, Inc.'>WMGI</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/INO' title='Inovio Pharmaceuticals, Inc.'>INO</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/YOKU' title='Youku Tudou Inc.'>YOKU</a> <font color='red'>-9%</font>. WWWW <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/ARRY' title='Array BioPharma Inc.'>ARRY</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/AVG' title='AVG Technologies'>AVG</a> <font color='red'>-5%</font>. <a href='https://seekingalpha.com/symbol/EBIX' title='Ebix Inc'>EBIX</a> <font color='red'>-%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1211982\" data-linked=\"Premarket Gainers / Losers\" data-tweet=\"$UI $GERN $MEET - Premarket Gainers / Losers https://seekingalpha.com/news/1211982-premarket-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/1211982-premarket-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1211762\" data-ts=\"1376053560\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JRCCQ\" target=\"_blank\">JRCCQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1211762-james-river-coal-plus-9-percent-following-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">James River Coal +9% following Q2 results</a></h4><ul>     <li>James River Coal (JRCC) <font color=\"green\">+9%</font> despite a 42% drop in Q2 revenue due to weak coal prices, as a 36% decline in costs helped JRCC report a <a href=\"https://seekingalpha.com/currents/post/1211032\" target=\"_blank\">smaller-than-expected Q2 loss</a>.</li>     <li>A $101.2M pretax gain helped JRCC post an unadjusted net profit of $52.6M, or $1.16/share, vs. a loss of $25.8M, or $0.74/share, in the prior year earlier.</li>     <li>Met coal markets have \"clearly weakened\" in recent months, JRCC says; \"we are a little more cautious about met than we had been earlier this year.\"</li>     <li>Q2 coal shipments fell 26% to 2.16M tons; price per ton declined 22% to $69.72.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1211762\" data-linked=\"James River Coal +9% following Q2 results\" data-tweet=\"$JRCCQ - James River Coal +9% following Q2 results https://seekingalpha.com/news/1211762-james-river-coal-plus-9-percent-following-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/1211762-james-river-coal-plus-9-percent-following-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:06 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1211622\" data-ts=\"1376052499\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDR\" target=\"_blank\">MDR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1211622-mcdermott-gapping-higher-following-insider-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">McDermott gapping higher following insider buy</a></h4><ul>     <li>McDermott (NYSE:<a href=\"https://seekingalpha.com/symbol/MDR\" title=\"McDermott International, Inc.\">MDR</a>) <font color=\"green\">+3.2%</font> premarket as CEO/President/Chairman Stephen Marcum Johnson <a href=\"http://archive.fast-edgar.com/20130808/Aabytvnaa3-e-jc-4y-b2-8-d-8-kSl-f-3/\" target=\"_blank\">discloses</a> buying 74,180 shares at $6.70-$6.76, worth ~$500K, on Aug. 8.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1211622\" data-linked=\"McDermott gapping higher following insider buy\" data-tweet=\"$MDR - McDermott gapping higher following insider buy https://seekingalpha.com/news/1211622-mcdermott-gapping-higher-following-insider-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/1211622-mcdermott-gapping-higher-following-insider-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:48 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1211452\" data-ts=\"1376051370\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DNDN\" target=\"_blank\">DNDN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1211452-dendreon-worth-zero-wedbush\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dendreon worth zero: Wedbush</a></h4><ul>     <li>No need to sugarcoat it: The news out of Dendreon (NASDAQ:<a href=\"https://seekingalpha.com/symbol/DNDN\" title=\"Dendreon Corporation\">DNDN</a>) Thursday was bad. First, investors learned that the company has essentially <a href=\"https://seekingalpha.com/currents/post/1209912\" target=\"_blank\">abandoned the notion</a> of posting Y/Y sales growth for Provenge in H2 and second, DNDN says CFO Greg Schiffman is <a href=\"https://seekingalpha.com/currents/post/1210032\" target=\"_blank\">leaving the company</a> come December.<br>     </li>     <li>The prospects for the company look decisively grim according to nearly everyone who has cared to comment.</li>     <li>Wedbush has actually <strong>cut its price target on the stock to $0</strong>, saying there is nothing ahead but a \"painful restructuring\" and a wipeout for equity investors. (<a href=\"https://twitter.com/adamfeuerstein/status/365788656289599488/photo/1\" target=\"_blank\">analyst note</a>)</li>     <li>TheStreet's Adam Feuerstein says the CFO exit <a href=\"http://www.thestreet.com/story/12004037/1/the-provenge-anchor-is-sinking-dendreon.html\" target=\"_blank\">raises even more questions</a> about the company's viability.</li>     <li>Bernstein's take: \"What can be said? It keeps <a href=\"https://twitter.com/matthewherper/status/365795873789186052\" target=\"_blank\">getting worse</a>.\"</li>     <li>Shares <font color=\"red\">-13%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1211452\" data-linked=\"Dendreon worth zero: Wedbush\" data-tweet=\"$DNDN - Dendreon worth zero: Wedbush https://seekingalpha.com/news/1211452-dendreon-worth-zero-wedbush?source=tweet\" data-url=\"https://seekingalpha.com/news/1211452-dendreon-worth-zero-wedbush\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1211442\" data-ts=\"1376051261\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NEWL\" target=\"_blank\">NEWL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1211442-newlead-surges-as-nasdaq-approves-compliance-plan\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NewLead surges as Nasdaq approves compliance plan</a></h4><ul>     <li>NewLead Holdings (NASDAQ:<a href=\"https://seekingalpha.com/symbol/NEWL\" title=\"NewLead Holdings Ltd.\">NEWL</a>) says Nasdaq approved  its plan to regain compliance, which will permit the continued listing of its common stock on the NASDAQ Global Select Market.</li>     <li>Shares <font color=\"green\">+66.5%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1211442\" data-linked=\"NewLead surges as Nasdaq approves compliance plan\" data-tweet=\"$NEWL - NewLead surges as Nasdaq approves compliance plan https://seekingalpha.com/news/1211442-newlead-surges-as-nasdaq-approves-compliance-plan?source=tweet\" data-url=\"https://seekingalpha.com/news/1211442-newlead-surges-as-nasdaq-approves-compliance-plan\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:27 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1211432\" data-ts=\"1376050923\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ROAN\" target=\"_blank\">ROAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1211432-linn-energy-minus-3_2-percent-premarket-following-yesterdays-6-percent-drubbing\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Linn Energy -3.2% premarket following yesterday&#39;s 6% drubbing</a></h4><ul>     <li>Linn Energy (LINE) <font color=\"red\">-3.2%</font> premarket following <a href=\"https://seekingalpha.com/currents/post/1208582\" target=\"_blank\">yesterday's 6% drubbing</a>, as Oppenheimer <a href=\"http://www.streetinsider.com/Downgrades/Oppenheimer+Downgrades+LINN+Energy+%28LINE%29+to+Underperform/8585506.html\" target=\"_blank\">downgrades</a> shares to Underperform with a $23 price target.</li>     <li>The firm believes the Berry (NASDAQ:<a href=\"https://seekingalpha.com/symbol/BRY\" title=\"Berry Petroleum Corp.\">BRY</a>) acquisition is in jeopardy, with LinnCo (LNCO) trading significantly lower than when the deal was announced.</li>     <li>There's also concern about LINE's maintenance capital budgeting, with questions about the true level of sustainable distribution.</li>     <li>Finally, the informal SEC inquiry is ongoing and the balance sheet is a bit stretched.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1211432\" data-linked=\"Linn Energy -3.2% premarket following yesterday&#39;s 6% drubbing\" data-tweet=\"$ROAN $ROAN $LNCOQ - Linn Energy -3.2% premarket following yesterday&#39;s 6% drubbing https://seekingalpha.com/news/1211432-linn-energy-minus-3_2-percent-premarket-following-yesterdays-6-percent-drubbing?source=tweet\" data-url=\"https://seekingalpha.com/news/1211432-linn-energy-minus-3_2-percent-premarket-following-yesterdays-6-percent-drubbing\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>27&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1211272\" data-ts=\"1376049440\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FL\" target=\"_blank\">FL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1211272-foot-locker-cut-to-neutral-at-goldman-shares-minus-1_9-percent-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Foot Locker cut to Neutral at Goldman, shares -1.9% premarket</a></h4><ul>     <li>Foot Locker (NYSE:<a href=\"https://seekingalpha.com/symbol/FL\" title=\"Foot Locker, Inc.\">FL</a>) <font color=\"red\">-1.9%</font> premarket after Goldman Sachs <a href=\"http://www.streetinsider.com/Analyst+Comments/Goldman+Sachs+Downgrades+Foot+Locker+%28FL%29+to+Neutral%2C+Less+Reasons+to+Own/8585615.html\" target=\"_blank\">downgrades</a> shares to Neutral from Buy with a $37 price target, down from $41, citing a lack of conviction in same-store sales re-acceleration.</li>     <li>FL has become a \"share donor\" to vendors\u2019 direct operations, particularly at Nike (NYSE:<a href=\"https://seekingalpha.com/symbol/NKE\" title=\"Nike Inc.\">NKE</a>), and more recently to non-athletic retailers, the firm says; this, combined with slowing sales across  many athletic brands, lessens conviction in a same-store sales pickup, which the firm sees as a necessary catalyst for the stock to re-rate.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1211272\" data-linked=\"Foot Locker cut to Neutral at Goldman, shares -1.9% premarket\" data-tweet=\"$FL $FL $NKE - Foot Locker cut to Neutral at Goldman, shares -1.9% premarket https://seekingalpha.com/news/1211272-foot-locker-cut-to-neutral-at-goldman-shares-minus-1_9-percent-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/1211272-foot-locker-cut-to-neutral-at-goldman-shares-minus-1_9-percent-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:57 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1211132\" data-ts=\"1376047668\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BB\" target=\"_blank\">BB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1211132-blackberry-shares-surge-on-buyout-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BlackBerry shares surge on buyout report</a></h4><ul>   <li>BlackBerry (BBRY) shares <font color=\"green\">jump 10.5%</font> following a report that CEO Thorsten Heins and the company's board are considering t<a href=\"https://seekingalpha.com/currents/post/1210702\" target=\"_blank\">aking the company private</a>.</li>    <li>As with Dell, the idea would be to try to fix the company's problems away from the unforgiving glare of Wall Street.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1211132\" data-linked=\"BlackBerry shares surge on buyout report\" data-tweet=\"$BB - BlackBerry shares surge on buyout report https://seekingalpha.com/news/1211132-blackberry-shares-surge-on-buyout-report?source=tweet\" data-url=\"https://seekingalpha.com/news/1211132-blackberry-shares-surge-on-buyout-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1210842\" data-ts=\"1376039290\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1210842-european-stocks-mixed\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">European stocks mixed</a></h4><ul>   <li><a href=\"http://www.marketwatch.com/story/europe-stocks-rise-for-second-day-after-china-data-2013-08-09-41032656\" target=\"_blank\">European shares</a> are mostly lower despite some decent Chinese economic data.</li>    <li>KPN shares <font color='green'>+17%</font> on news that America Movil is <a href=\"https://seekingalpha.com/currents/post/1210712\" target=\"_blank\">launching an offer</a> to buy the Dutch telecom operator.</li>    <li>EU Stoxx 50 <font color='red'>-0.1%</font>, London <font color='green'>+0.1%</font>, Paris <font color='red'>-0.2%</font>, Frankfurt <font color='red'>-0.3%</font>, Madrid <font color='red'>-0.3%</font>, Milan <font color='red'>-0.2%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1210842\" data-linked=\"European stocks mixed\" data-tweet=\"European stocks mixed https://seekingalpha.com/news/1210842-european-stocks-mixed?source=tweet\" data-url=\"https://seekingalpha.com/news/1210842-european-stocks-mixed\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:08 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1210832\" data-ts=\"1376038540\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1210832-asian-shares-higher-in-wake-of-positive-chinese-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Asian shares higher in wake of positive Chinese data</a></h4><ul>   <li>\n<a href=\"http://www.bloomberg.com/news/2013-08-09/most-asian-stocks-rise-on-china-growth-outlook-u-s-jobs.html\" target=\"_blank\">Asian stocks</a> rise following more evidence that China's economic slowdown is stabilizing, with industrial production <a href=\"https://seekingalpha.com/currents/post/1210722\" target=\"_blank\">beating consensus</a>, while inflation remains <a href=\"https://seekingalpha.com/currents/post/1210732\" target=\"_blank\">tame</a>.</li>   <li>Japan <font color=\"green\">+0.1%</font> , Hong Kong <font color=\"green\">+0.7%,</font> China <font color=\"green\">+0.4%</font>, India <font color=\"green\">+0.7%</font>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"1210832\" data-linked=\"Asian shares higher in wake of positive Chinese data\" data-tweet=\"Asian shares higher in wake of positive Chinese data https://seekingalpha.com/news/1210832-asian-shares-higher-in-wake-of-positive-chinese-data?source=tweet\" data-url=\"https://seekingalpha.com/news/1210832-asian-shares-higher-in-wake-of-positive-chinese-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:55 AM </div></div></li>","count":73,"message":null,"success":true,"today":{"start":1576818000,"end":1576904399,"str":"Friday, December 20, 2019"},"yesterday":{"start":1576731600,"end":1576817999}}